| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19B ABCA3 ABCF3 ATRX MYO7A CHD1 DDX1 ACSL1 MYO3A MDN1 DDX50 KIF2A KIF5A HSPA1L HSPA2 HSPA6 HSPA7 RAD51B ACSL6 DYNC2H1 MYO18A CHD9 ZNFX1 ACSF2 SMC3 ATF7IP CHTF18 MYO1F DDX25 MACF1 ABCC12 KIF18B DNAH11 CDK7 | 1.24e-10 | 614 | 308 | 34 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX19B ABCA3 ABCF3 ATRX CHD1 DDX1 MDN1 DDX50 KIF2A KIF5A HSPA1L HSPA2 HSPA6 HSPA7 RAD51B DYNC2H1 MYO18A CHD9 SMC3 ATF7IP CHTF18 DDX25 MACF1 ABCC12 KIF18B DNAH11 | 5.86e-09 | 441 | 308 | 26 | GO:0016887 |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 5.55e-08 | 4 | 308 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 5.55e-08 | 4 | 308 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 5.55e-08 | 4 | 308 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 2.74e-07 | 5 | 308 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 2.74e-07 | 5 | 308 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 2.74e-07 | 5 | 308 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 2.74e-07 | 5 | 308 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 2.74e-07 | 5 | 308 | 4 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 2.74e-07 | 5 | 308 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 2.74e-07 | 5 | 308 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 8.13e-07 | 6 | 308 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 1.87e-06 | 7 | 308 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 3.70e-06 | 8 | 308 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 3.70e-06 | 8 | 308 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 3.70e-06 | 8 | 308 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 6.58e-06 | 9 | 308 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 6.58e-06 | 9 | 308 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | bile acid binding | 1.08e-05 | 10 | 308 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 1.08e-05 | 10 | 308 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYO7A MYO3A KIF2A KIF5A DYNC2H1 MYO18A SMC3 MYO1F KIF18B DNAH11 | 1.48e-05 | 118 | 308 | 10 | GO:0003774 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 3.17e-05 | 40 | 308 | 6 | GO:0016709 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX19B ABCA3 ABCF3 ATRX CHD1 DDX1 MDN1 DDX50 KIF2A KIF5A HSPA1L HSPA2 HSPA6 HSPA7 RAD51B DCPS DYNC2H1 MYO18A CHD9 NUDT4 SMC3 RERGL ATF7IP CHTF18 DDX25 MACF1 ABCC12 KIF18B DNAH11 | 4.57e-05 | 839 | 308 | 29 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX19B ABCA3 ABCF3 ATRX CHD1 DDX1 MDN1 DDX50 KIF2A KIF5A HSPA1L HSPA2 HSPA6 HSPA7 RAD51B DCPS DYNC2H1 MYO18A CHD9 NUDT4 SMC3 RERGL ATF7IP CHTF18 DDX25 MACF1 ABCC12 KIF18B DNAH11 | 4.67e-05 | 840 | 308 | 29 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX19B ABCA3 ABCF3 ATRX CHD1 DDX1 MDN1 DDX50 KIF2A KIF5A HSPA1L HSPA2 HSPA6 HSPA7 RAD51B DCPS DYNC2H1 MYO18A CHD9 NUDT4 SMC3 RERGL ATF7IP CHTF18 DDX25 MACF1 ABCC12 KIF18B DNAH11 | 4.67e-05 | 840 | 308 | 29 | GO:0016818 |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 4.92e-05 | 14 | 308 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 4.92e-05 | 14 | 308 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX19B ABCA3 ABCF3 ATRX CHD1 DDX1 MDN1 DDX50 KIF2A KIF5A HSPA1L HSPA2 HSPA6 HSPA7 RAD51B DYNC2H1 MYO18A CHD9 SMC3 RERGL ATF7IP CHTF18 DDX25 MACF1 ABCC12 KIF18B DNAH11 | 7.39e-05 | 775 | 308 | 27 | GO:0017111 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 1.11e-04 | 95 | 308 | 8 | GO:0016651 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 2.21e-04 | 20 | 308 | 4 | GO:0004303 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 3.19e-04 | 60 | 308 | 6 | GO:0016655 | |
| GeneOntologyMolecularFunction | NADP binding | 3.82e-04 | 62 | 308 | 6 | GO:0050661 | |
| GeneOntologyMolecularFunction | ligase activity | 3.83e-04 | 174 | 308 | 10 | GO:0016874 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 4.15e-04 | 115 | 308 | 8 | GO:0004497 | |
| GeneOntologyMolecularFunction | protein kinase activity | ERBB3 DAPK1 CDKL5 MYO3A MAP3K11 MAP3K15 FGR NME2 KALRN NRG2 SGK2 CHEK2 PRKACG DCLK3 PKN1 LYN HCK ALPK2 MAP3K2 CDK6 CDK7 | 4.42e-04 | 600 | 308 | 21 | GO:0004672 |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 4.62e-04 | 24 | 308 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 5.47e-04 | 11 | 308 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | DAPK1 CDKL5 MYO3A MAP3K11 MAP3K15 KALRN SGK2 CHEK2 PRKACG DCLK3 PKN1 ALPK2 MAP3K2 CDK6 CDK7 | 5.52e-04 | 363 | 308 | 15 | GO:0106310 |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 6.35e-04 | 26 | 308 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 6.35e-04 | 26 | 308 | 4 | GO:0070402 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERBB3 TENT5C DAPK1 PFKFB2 CDKL5 MYO3A MAP3K11 MAP3K15 FGR NME1 NME2 KALRN POLE TENT5A NRG2 TEP1 TENT5B SGK2 CHEK2 PRKACG DCLK3 PKN1 LYN HCK ALPK2 MAP3K2 CDK6 CDK7 | 6.79e-04 | 938 | 308 | 28 | GO:0016772 |
| GeneOntologyMolecularFunction | poly(A) RNA polymerase activity | 7.21e-04 | 12 | 308 | 3 | GO:1990817 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 7.35e-04 | 70 | 308 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 7.36e-04 | 27 | 308 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | helicase activity | 7.94e-04 | 158 | 308 | 9 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 8.03e-04 | 127 | 308 | 8 | GO:0008094 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ATRX CHD1 DDX1 NME1 MBD4 RAD51B POLE MYO18A CHD9 TEP1 CHTF18 CDK7 | 8.07e-04 | 262 | 308 | 12 | GO:0140097 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | TET2 CYP2J2 AKR1C4 AKR1C1 AKR1C2 PTGS2 MICAL1 FMO2 TH AKR1C3 | 8.94e-04 | 194 | 308 | 10 | GO:0016705 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO7A TTLL9 SPTA1 MTSS1 TOGARAM1 MYO3A DST KCNC1 SNX6 KIF2A KIF5A PLEC NME1 PLEKHH2 HSPA2 MICAL1 GTSE1 MYO18A MIB2 SORBS1 TRAK1 SMC3 INF2 TRIM32 TTLL4 MYO1F MACF1 FHDC1 CCDC181 KIF18B LYN | 8.95e-04 | 1099 | 308 | 31 | GO:0008092 |
| GeneOntologyMolecularFunction | protein folding chaperone | 9.18e-04 | 73 | 308 | 6 | GO:0044183 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.11e-03 | 30 | 308 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity | 1.39e-03 | 4 | 308 | 2 | GO:0050510 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 1.39e-03 | 4 | 308 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 1.42e-03 | 32 | 308 | 4 | GO:0004033 | |
| GeneOntologyMolecularFunction | long-chain fatty acid-CoA ligase activity | 1.44e-03 | 15 | 308 | 3 | GO:0004467 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ERBB3 DAPK1 PFKFB2 CDKL5 MYO3A MAP3K11 MAP3K15 FGR NME2 KALRN NRG2 SGK2 CHEK2 PRKACG DCLK3 PKN1 LYN HCK ALPK2 MAP3K2 CDK6 CDK7 | 1.57e-03 | 709 | 308 | 22 | GO:0016773 |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.60e-03 | 33 | 308 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | DAPK1 CDKL5 MYO3A MAP3K11 MAP3K15 NME2 KALRN SGK2 CHEK2 PRKACG DCLK3 PKN1 ALPK2 MAP3K2 CDK6 CDK7 | 1.62e-03 | 446 | 308 | 16 | GO:0004674 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 1.79e-03 | 34 | 308 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | kinase activity | ERBB3 DAPK1 PFKFB2 CDKL5 MYO3A MAP3K11 MAP3K15 FGR NME1 NME2 KALRN NRG2 SGK2 CHEK2 PRKACG DCLK3 PKN1 LYN HCK ALPK2 MAP3K2 CDK6 CDK7 | 1.82e-03 | 764 | 308 | 23 | GO:0016301 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | DDX19B ATRX CHD1 DDX1 DDX50 NME1 MBD4 RAD51B WARS1 DCPS POLE MYO18A FARSB CHD9 ZNFX1 LARS2 TEP1 CHTF18 DDX25 CDK7 | 2.55e-03 | 645 | 308 | 20 | GO:0140640 |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 2.98e-03 | 39 | 308 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 3.28e-03 | 40 | 308 | 4 | GO:0140662 | |
| GeneOntologyMolecularFunction | ErbB-3 class receptor binding | 3.41e-03 | 6 | 308 | 2 | GO:0043125 | |
| GeneOntologyMolecularFunction | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | 3.41e-03 | 6 | 308 | 2 | GO:0047238 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.59e-03 | 127 | 308 | 7 | GO:0016616 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 4.75e-08 | 4 | 306 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 4.75e-08 | 4 | 306 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 4.75e-08 | 4 | 306 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 4.75e-08 | 4 | 306 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 2.35e-07 | 5 | 306 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 2.35e-07 | 5 | 306 | 4 | GO:0120256 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 2.35e-07 | 5 | 306 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 2.35e-07 | 5 | 306 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 2.35e-07 | 5 | 306 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 2.35e-07 | 5 | 306 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 6.96e-07 | 6 | 306 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 6.96e-07 | 6 | 306 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 1.61e-06 | 7 | 306 | 4 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 1.61e-06 | 7 | 306 | 4 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 1.61e-06 | 7 | 306 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 2.91e-06 | 28 | 306 | 6 | GO:0048025 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 3.62e-06 | 29 | 306 | 6 | GO:0050686 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 5.64e-06 | 9 | 306 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 8.02e-06 | 33 | 306 | 6 | GO:0033119 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 9.30e-06 | 10 | 306 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 9.30e-06 | 10 | 306 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 9.30e-06 | 10 | 306 | 4 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 9.30e-06 | 10 | 306 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 9.30e-06 | 10 | 306 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 1.16e-05 | 21 | 306 | 5 | GO:0048385 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.44e-05 | 11 | 306 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.44e-05 | 11 | 306 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleotide biosynthetic process | 1.44e-05 | 11 | 306 | 4 | GO:0009221 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 1.49e-05 | 22 | 306 | 5 | GO:0016137 | |
| GeneOntologyBiologicalProcess | parturition | 1.49e-05 | 22 | 306 | 5 | GO:0007567 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 4.23e-05 | 14 | 306 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 4.23e-05 | 14 | 306 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | TENT5C AKR1C4 AKR1C1 HNRNPA2B1 AKR1C2 SFSWAP TENT5A TENT5B AKR1C3 | 5.50e-05 | 115 | 306 | 9 | GO:1903312 |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 5.70e-05 | 15 | 306 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 6.53e-05 | 47 | 306 | 6 | GO:0046164 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleotide metabolic process | 7.31e-05 | 30 | 306 | 5 | GO:0009219 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 7.51e-05 | 16 | 306 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 7.51e-05 | 16 | 306 | 4 | GO:0032351 | |
| GeneOntologyBiologicalProcess | vesicle localization | SYN3 MYO7A UNC13D TRAPPC6B SYT4 KIF5A TRAPPC2 UNC13B AP1M2 IKBKG TRAPPC2B TRAK1 CTBP1 | 8.76e-05 | 247 | 306 | 13 | GO:0051648 |
| GeneOntologyBiologicalProcess | dTMP biosynthetic process | 1.08e-04 | 7 | 306 | 3 | GO:0006231 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 1.08e-04 | 7 | 306 | 3 | GO:0009177 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 1.23e-04 | 18 | 306 | 4 | GO:0030656 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.36e-04 | 34 | 306 | 5 | GO:0006706 | |
| GeneOntologyBiologicalProcess | 2'-deoxyribonucleotide biosynthetic process | 1.54e-04 | 19 | 306 | 4 | GO:0009265 | |
| GeneOntologyBiologicalProcess | deoxyribonucleotide biosynthetic process | 1.54e-04 | 19 | 306 | 4 | GO:0009263 | |
| GeneOntologyBiologicalProcess | deoxyribose phosphate biosynthetic process | 1.54e-04 | 19 | 306 | 4 | GO:0046385 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 1.77e-04 | 56 | 306 | 6 | GO:0006693 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 1.80e-04 | 36 | 306 | 5 | GO:0034694 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 1.95e-04 | 57 | 306 | 6 | GO:0006692 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 1.95e-04 | 57 | 306 | 6 | GO:0042181 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | SCN11A MYO7A UNC13D MDN1 SNX6 TRAPPC6B SYT4 KIF5A FGR ARHGAP21 TRAPPC2 UNC13B AP1M2 IKBKG TACC2 TRAPPC2B TRAK1 KASH5 LYN GPSM1 | 2.06e-04 | 546 | 306 | 20 | GO:0051656 |
| GeneOntologyBiologicalProcess | hormone catabolic process | 2.33e-04 | 21 | 306 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 2.33e-04 | 21 | 306 | 4 | GO:0016114 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 2.33e-04 | 21 | 306 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 2.33e-04 | 21 | 306 | 4 | GO:0042574 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 2.34e-04 | 38 | 306 | 5 | GO:0048384 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 2.81e-04 | 22 | 306 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 2.81e-04 | 22 | 306 | 4 | GO:1902644 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 3.37e-04 | 23 | 306 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 3.37e-04 | 23 | 306 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | organelle localization | SCN11A SYN3 MYO7A UNC13D MDN1 SNX6 TRAPPC6B SYT4 KIF5A FGR ARHGAP21 TRAPPC2 UNC13B NUP98 AP1M2 IKBKG TACC2 TRAPPC2B TRAK1 KASH5 CTBP1 LYN GPSM1 | 3.57e-04 | 703 | 306 | 23 | GO:0051640 |
| GeneOntologyBiologicalProcess | L-leucine metabolic process | 3.59e-04 | 10 | 306 | 3 | GO:0006551 | |
| GeneOntologyBiologicalProcess | response to heat | 4.52e-04 | 121 | 306 | 8 | GO:0009408 | |
| GeneOntologyBiologicalProcess | poly(A)+ mRNA export from nucleus | 4.70e-04 | 25 | 306 | 4 | GO:0016973 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 4.74e-04 | 67 | 306 | 6 | GO:0019748 | |
| GeneOntologyBiologicalProcess | microtubule-based process | ATRX TTLL9 TOGARAM1 NCKAP5 ENO4 TBC1D32 DST MAP3K11 MAP7D2 KIF2A KIF5A ARHGAP21 CFAP47 CFAP91 DYNC2H1 GTSE1 TACC2 CCDC39 TRAK1 DNAAF2 PPP2R1A KASH5 SMC3 TTLL4 CHEK2 MACF1 KIF18B GPSM1 AGRN DNAH11 | 5.37e-04 | 1058 | 306 | 30 | GO:0007017 |
| GeneOntologyBiologicalProcess | establishment of vesicle localization | MYO7A UNC13D TRAPPC6B SYT4 KIF5A TRAPPC2 UNC13B AP1M2 IKBKG TRAPPC2B TRAK1 | 5.45e-04 | 224 | 306 | 11 | GO:0051650 |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 5.49e-04 | 26 | 306 | 4 | GO:0010566 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 5.55e-04 | 69 | 306 | 6 | GO:0070542 | |
| GeneOntologyBiologicalProcess | deoxyribonucleoside monophosphate biosynthetic process | 6.44e-04 | 12 | 306 | 3 | GO:0009157 | |
| GeneOntologyBiologicalProcess | positive regulation of long-chain fatty acid import across plasma membrane | 6.52e-04 | 3 | 306 | 2 | GO:0010747 | |
| GeneOntologyBiologicalProcess | leukocyte migration involved in immune response | 6.52e-04 | 3 | 306 | 2 | GO:0002522 | |
| GeneOntologyBiologicalProcess | dense core granule localization | 7.34e-04 | 28 | 306 | 4 | GO:0032253 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 7.51e-04 | 73 | 306 | 6 | GO:1901616 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB3 signaling pathway | 8.28e-04 | 13 | 306 | 3 | GO:0038133 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 8.42e-04 | 29 | 306 | 4 | GO:0016093 | |
| GeneOntologyCellularComponent | cytoplasmic region | DZIP1L TOGARAM1 HNRNPA2B1 CDKL5 DST KIF5A BRWD1 UNC13B CFAP91 EFCAB6 DYNC2H1 CCDC39 TRAK1 EFHC2 CTBP1 DNAH11 | 9.23e-05 | 360 | 307 | 16 | GO:0099568 |
| GeneOntologyCellularComponent | actin cytoskeleton | DENND2A MYO7A SPTA1 MTSS1 DAPK1 PGM5 MYO3A DST FGR PLEKHH2 ARHGAP21 FERMT3 MICAL1 KALRN MYO18A SORBS1 INF2 MYO1F MACF1 FHDC1 HCK | 1.33e-04 | 576 | 307 | 21 | GO:0015629 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TTLL9 TOGARAM1 NCKAP5 SYNC RASSF5 MYO3A DST SYNJ2 MAP3K11 KIF2A KIF5A PLEC NME1 NME2 MICAL1 EFCAB6 DYNC2H1 GTSE1 EFHC2 INF2 TTLL4 MYO1F MACF1 FHDC1 CCDC181 KIF18B HCK DNAH11 | 1.58e-04 | 899 | 307 | 28 | GO:0099513 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | DZIP1L TOGARAM1 HNRNPA2B1 CDKL5 DST KIF5A BRWD1 CFAP91 EFCAB6 DYNC2H1 CCDC39 TRAK1 EFHC2 DNAH11 | 2.68e-04 | 317 | 307 | 14 | GO:0032838 |
| GeneOntologyCellularComponent | outer membrane | DAO PTGS2 ACSL1 MIEF1 PLEC NME1 IMMT TRAPPC2 ACSL6 ZNFX1 TRAPPC2B ANKH KASH5 | 2.83e-04 | 281 | 307 | 13 | GO:0019867 |
| GeneOntologyCellularComponent | supramolecular fiber | TTLL9 TOGARAM1 NCKAP5 SYNC RYR2 PGM5 RASSF5 MYO3A DST SYNJ2 MAP3K11 KIF2A KIF5A PLEC NME1 NME2 MICAL1 EFCAB6 DYNC2H1 GTSE1 MYO18A EFHC2 PPP3CA INF2 TRIM32 TTLL4 MYO1F MACF1 FHDC1 CCDC181 KIF18B HCK DNAH11 | 2.97e-04 | 1179 | 307 | 33 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TTLL9 TOGARAM1 NCKAP5 SYNC RYR2 PGM5 RASSF5 MYO3A DST SYNJ2 MAP3K11 KIF2A KIF5A PLEC NME1 NME2 MICAL1 EFCAB6 DYNC2H1 GTSE1 MYO18A EFHC2 PPP3CA INF2 TRIM32 TTLL4 MYO1F MACF1 FHDC1 CCDC181 KIF18B HCK DNAH11 | 3.35e-04 | 1187 | 307 | 33 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule | TTLL9 TOGARAM1 NCKAP5 RASSF5 DST SYNJ2 MAP3K11 KIF2A KIF5A EFCAB6 DYNC2H1 GTSE1 EFHC2 TTLL4 MACF1 FHDC1 CCDC181 KIF18B DNAH11 | 3.66e-04 | 533 | 307 | 19 | GO:0005874 |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 4.25e-04 | 185 | 307 | 10 | GO:0009898 | |
| GeneOntologyCellularComponent | TRAPPII protein complex | 6.25e-04 | 12 | 307 | 3 | GO:1990071 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | DDX19B ATXN2L HNRNPA2B1 DDX1 KIF5A FAM184A DCPS POLDIP3 PABPC4L ZNFX1 SARNP DDX25 | 6.65e-04 | 269 | 307 | 12 | GO:0036464 |
| GeneOntologyCellularComponent | organelle outer membrane | DAO PTGS2 ACSL1 MIEF1 PLEC NME1 IMMT TRAPPC2 ACSL6 ZNFX1 TRAPPC2B KASH5 | 9.14e-04 | 279 | 307 | 12 | GO:0031968 |
| GeneOntologyCellularComponent | ruffle | 9.77e-04 | 206 | 307 | 10 | GO:0001726 | |
| GeneOntologyCellularComponent | ruffle membrane | 1.08e-03 | 108 | 307 | 7 | GO:0032587 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | DDX19B ATXN2L HNRNPA2B1 DDX1 KIF5A FAM184A DCPS POLDIP3 PABPC4L ZNFX1 SARNP DDX25 | 1.17e-03 | 287 | 307 | 12 | GO:0035770 |
| MousePheno | parturition failure | 3.09e-07 | 10 | 236 | 5 | MP:0012010 | |
| MousePheno | long stride length | 3.44e-06 | 15 | 236 | 5 | MP:0010540 | |
| MousePheno | long gestation period | 3.44e-06 | 15 | 236 | 5 | MP:0002293 | |
| MousePheno | abnormal gait | GDF5 MYO7A DAPK1 AKR1C4 AKR1C1 AKR1C2 PTHLH DST SACS COQ9 SYT4 IMMT BAHCC1 GPD1 WARS1 WASHC4 TENT5A POU3F4 ANKH TRAK1 LRIG3 TH AKR1C3 LYN | 7.99e-06 | 520 | 236 | 24 | MP:0001406 |
| MousePheno | abnormal gestational length | 9.41e-06 | 18 | 236 | 5 | MP:0002292 | |
| MousePheno | abnormal parturition | 1.64e-05 | 33 | 236 | 6 | MP:0002907 | |
| MousePheno | abnormal muscle fiber mitochondrial morphology | 1.64e-05 | 33 | 236 | 6 | MP:0014342 | |
| MousePheno | dysmyelination | 1.66e-05 | 20 | 236 | 5 | MP:0013438 | |
| MousePheno | hypermyelination | 2.38e-05 | 11 | 236 | 4 | MP:0010050 | |
| MousePheno | abnormal locomotor coordination | GDF5 MYO7A DAO DAPK1 AKR1C4 AKR1C1 AKR1C2 PTHLH DST SACS COQ9 SYT4 IMMT BAHCC1 GPD1 WARS1 WASHC4 TENT5A POU3F4 ANKH TRAK1 KCNV1 LRIG3 TH AKR1C3 LYN AGRN MTMR9 | 3.81e-05 | 726 | 236 | 28 | MP:0003312 |
| MousePheno | increased oligodendrocyte number | 5.02e-05 | 13 | 236 | 4 | MP:0010160 | |
| MousePheno | increased circulating progesterone level | 9.34e-05 | 15 | 236 | 4 | MP:0005186 | |
| MousePheno | right-sided stomach | 1.56e-04 | 31 | 236 | 5 | MP:0010808 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.30e-05 | 10 | 302 | 4 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 1.30e-05 | 10 | 302 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.30e-05 | 10 | 302 | 4 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.30e-05 | 10 | 302 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.30e-05 | 10 | 302 | 4 | PS00063 | |
| Domain | DUF1693 | 1.65e-05 | 4 | 302 | 3 | IPR012937 | |
| Domain | DUF1693 | 1.65e-05 | 4 | 302 | 3 | SM01153 | |
| Domain | NTP_transf_7 | 1.65e-05 | 4 | 302 | 3 | PF07984 | |
| Domain | P-loop_NTPase | DDX19B ABCA3 ABCF3 ATRX MYO7A DAPK1 CHD1 PFKFB2 DDX1 EHD4 MYO3A MDN1 DDX50 KIF2A IFI44L KIF5A RAD51B DYNC2H1 MYO18A CHD9 ZNFX1 TEP1 SMC3 RERGL CHTF18 MYO1F DDX25 ABCC12 KIF18B HS6ST3 DNAH11 | 2.05e-05 | 848 | 302 | 31 | IPR027417 |
| Domain | Kinase-like_dom | ERBB3 DAPK1 CDKL5 MYO3A DST MAP3K11 MAP3K15 FGR KALRN CHD9 SGK2 CHEK2 PRKACG DCLK3 MACF1 PKN1 LYN HCK ALPK2 MAP3K2 CDK6 CDK7 SOS1 | 2.67e-05 | 542 | 302 | 23 | IPR011009 |
| Domain | - | 8.08e-05 | 6 | 302 | 3 | 3.90.1290.10 | |
| Domain | Spectrin_repeat | 9.23e-05 | 29 | 302 | 5 | IPR002017 | |
| Domain | - | 1.05e-04 | 16 | 302 | 4 | 3.20.20.100 | |
| Domain | HSP70 | 1.05e-04 | 16 | 302 | 4 | PF00012 | |
| Domain | NADP_OxRdtase_dom | 1.35e-04 | 17 | 302 | 4 | IPR023210 | |
| Domain | HSP70_2 | 1.35e-04 | 17 | 302 | 4 | PS00329 | |
| Domain | HSP70_1 | 1.35e-04 | 17 | 302 | 4 | PS00297 | |
| Domain | Aldo_ket_red | 1.35e-04 | 17 | 302 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 1.35e-04 | 17 | 302 | 4 | IPR001395 | |
| Domain | HSP70_3 | 1.35e-04 | 17 | 302 | 4 | PS01036 | |
| Domain | Plectin | 1.40e-04 | 7 | 302 | 3 | PF00681 | |
| Domain | Plectin_repeat | 1.40e-04 | 7 | 302 | 3 | IPR001101 | |
| Domain | PLEC | 1.40e-04 | 7 | 302 | 3 | SM00250 | |
| Domain | SPEC | 1.50e-04 | 32 | 302 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.50e-04 | 32 | 302 | 5 | IPR018159 | |
| Domain | Hsp_70_fam | 1.71e-04 | 18 | 302 | 4 | IPR013126 | |
| Domain | Spectrin | 4.66e-04 | 23 | 302 | 4 | PF00435 | |
| Domain | Protein_kinase_ATP_BS | DAPK1 CDKL5 MYO3A MAP3K11 MAP3K15 FGR KALRN SGK2 PRKACG DCLK3 PKN1 LYN HCK MAP3K2 CDK6 CDK7 | 4.78e-04 | 379 | 302 | 16 | IPR017441 |
| Domain | - | DDX19B ABCA3 ABCF3 ATRX MYO7A CHD1 PFKFB2 DDX1 EHD4 MDN1 DDX50 IFI44L RAD51B DYNC2H1 MYO18A CHD9 ZNFX1 TEP1 SMC3 RERGL CHTF18 MYO1F DDX25 ABCC12 DNAH11 | 4.92e-04 | 746 | 302 | 25 | 3.40.50.300 |
| Domain | PROTEIN_KINASE_ATP | ERBB3 DAPK1 CDKL5 MYO3A MAP3K11 MAP3K15 FGR KALRN SGK2 CHEK2 PRKACG DCLK3 PKN1 LYN HCK MAP3K2 CDK6 CDK7 | 5.18e-04 | 459 | 302 | 18 | PS00107 |
| Domain | K_chnl_volt-dep_ERG | 7.73e-04 | 3 | 302 | 2 | IPR003967 | |
| Domain | SH3 | MYO7A SPTA1 DST MAP3K11 FGR KALRN SORBS1 MYO1F MACF1 LYN HCK | 8.13e-04 | 216 | 302 | 11 | PS50002 |
| Domain | - | 8.26e-04 | 12 | 302 | 3 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 8.26e-04 | 12 | 302 | 3 | IPR029047 | |
| Domain | SH3_domain | MYO7A SPTA1 DST MAP3K11 FGR KALRN SORBS1 MYO1F MACF1 LYN HCK | 9.44e-04 | 220 | 302 | 11 | IPR001452 |
| Domain | - | 1.06e-03 | 13 | 302 | 3 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 1.06e-03 | 13 | 302 | 3 | IPR018181 | |
| Domain | HSP70_C | 1.06e-03 | 13 | 302 | 3 | IPR029048 | |
| Domain | Prot_kinase_dom | ERBB3 DAPK1 CDKL5 MYO3A MAP3K11 MAP3K15 FGR KALRN SGK2 CHEK2 PRKACG DCLK3 PKN1 LYN HCK MAP3K2 CDK6 CDK7 | 1.07e-03 | 489 | 302 | 18 | IPR000719 |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 8.45e-08 | 15 | 233 | 6 | MM14870 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 8.59e-06 | 9 | 233 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 8.59e-06 | 9 | 233 | 4 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 2.19e-05 | 11 | 233 | 4 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 4.63e-05 | 13 | 233 | 4 | MM14747 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 4.63e-05 | 13 | 233 | 4 | M17842 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 6.29e-05 | 61 | 233 | 7 | MM14861 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 6.39e-05 | 14 | 233 | 4 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 6.39e-05 | 14 | 233 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 6.39e-05 | 14 | 233 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 6.39e-05 | 14 | 233 | 4 | MM14748 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 8.60e-05 | 15 | 233 | 4 | MM1387 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | CYP2J2 ACOT13 AKR1C4 AKR1C1 AKR1C2 PTGS2 ACSL1 ACSL6 PTGES ACSF2 AKR1C3 | 1.22e-04 | 170 | 233 | 11 | MM15573 |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 1.46e-04 | 17 | 233 | 4 | M5940 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ABCF3 SNX17 PSMA7 RPS18 CHD1 MCCC1 UNC45A NDUFA9 HNRNPA2B1 NDUFS1 DDX1 EHD4 ACSL1 URB1 DST MDN1 UBN1 DDX50 CCDC47 GLYR1 KIF2A PLEC HSPA1L GCN1 IMMT HSPA6 KPNA1 WARS1 WASHC4 NOP56 RASA3 POLDIP3 TBPL1 POLE FARSB RICTOR PPP2R1A NOP14 SMC3 INF2 TRIM32 CHTF18 MACF1 IK KIF18B SRRM2 AGRN RPL13 HDLBP | 7.87e-17 | 1353 | 311 | 49 | 29467282 |
| Pubmed | RALGAPA1 ATXN2L DENND2A HDAC11 SYN3 MYO7A SPTA1 PSMA7 DAPK1 RPS18 LRRTM1 NDUFA9 HNRNPA2B1 PTGS2 NDUFS1 DDX1 EIF3CL CDKL5 DST SACS MAP7D2 KIF2A PLEC NME2 HSPA2 IMMT ARHGAP21 GOLGA3 ACSL6 MICAL1 WARS1 KALRN MYO18A FARSB ZNFX1 SORBS1 PPP2R1A PPP3CA INF2 KCTD10 STON2 LRRCC1 MACF1 CTBP1 HCK RPL13 DNAH11 HDLBP | 3.18e-15 | 1431 | 311 | 48 | 37142655 | |
| Pubmed | TET2 ERBB3 ATRX HLA-DRA NCKAP5 SYNC NCAPH2 TERF2IP DST SNX6 SACS MAP3K11 SYT4 KIF5A PLEC AMOTL2 MBD4 HSPA2 IMMT COG4 ARHGAP21 GOLGA3 KPNA1 BRWD1 UNC13B CFAP91 WARS1 WASHC4 KALRN CHD9 ZNFX1 SORBS1 THAP4 PPP3CA TRIM32 AKR1C3 LRRCC1 MACF1 CTBP1 RPL13 SOS1 | 2.03e-12 | 1285 | 311 | 41 | 35914814 | |
| Pubmed | ACER2 CAPN8 FAT1 TNRC18 DST UBN1 SACS GLYR1 MAP7D2 PLEC AMOTL2 GOLGA3 NSD2 TENT5A GTSE1 LARS2 ZBED6 ANKRD11 MACF1 ALPK2 | 2.87e-11 | 332 | 311 | 20 | 37433992 | |
| Pubmed | ABCF3 ATRX DZIP1L UNC13D AKR1C4 AKR1C1 AKR1C2 PTGS2 URB1 DDX50 GLYR1 KIF2A PLEC CPLANE1 COG4 ARHGAP21 BRWD1 WARS1 NOP56 SHMT1 FARSB RICTOR TMEM183BP TACC2 ANKRD50 INF2 TTLL4 AKR1C3 MACF1 IK CCDC171 HERC4 AGRN MAN1B1 CDK6 | 6.98e-11 | 1084 | 311 | 35 | 11544199 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO7A INTS1 PLEKHG1 URB1 FAT1 TNRC18 DST MDN1 UBN1 KCNH2 MAP3K11 PLEC GCN1 ARHGAP21 BAHCC1 UNC13B PNPLA2 RASA3 KALRN NSD2 POLE GTSE1 CHSY1 MIB2 LARS2 TEP1 HDAC7 TRAK1 MROH1 INF2 TTLL4 USP40 ANKRD11 PKN1 AGRN | 1.17e-10 | 1105 | 311 | 35 | 35748872 |
| Pubmed | SCN11A ATRX SPTA1 DZIP1L PSMA7 STOX1 HNRNPA2B1 NDUFS1 DDX1 RYR2 EHD4 TNRC18 DST MDN1 DDX50 SACS CCDC47 MANF MAP7D2 KIF5A PLEC NME1 NME2 HSPA1L HSPA2 IMMT HSPA6 ARHGAP21 BAHCC1 TRAPPC2 RAD51B NOP56 NSD2 NUP98 MYO18A CC2D1B NOP14 MACF1 CCDC158 RPL13 | 2.58e-10 | 1442 | 311 | 40 | 35575683 | |
| Pubmed | RALGAPA1 ATRX PSMA7 CHD1 UNC45A NDUFA9 HNRNPA2B1 NDUFS1 EHD4 PLEKHG1 URB1 MDN1 SNX6 SACS CCDC47 GLYR1 DNAJC9 MAP7D2 HSPA1L HSPA2 IMMT HSPA6 GOLGA3 FAM184A NOP56 DYNC2H1 POLE MYO18A SHMT1 RICTOR OXA1L NOP14 SLC4A1AP INF2 MRPS26 ANKRD11 MACF1 SRRM2 RPL13 HDLBP | 6.30e-10 | 1487 | 311 | 40 | 33957083 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ATXN2L ATRX RPS18 CHD1 MCCC1 HNRNPA2B1 DDX1 UBN1 DDX50 MANF NME1 NME2 MBD4 HSPA2 IMMT NOP56 SFSWAP NSD2 POLDIP3 GTSE1 NUP98 FARSB ZDBF2 SARNP SLC4A1AP ATF7IP ANKRD11 IK KIF18B SRRM2 HDLBP | 7.89e-10 | 954 | 311 | 31 | 36373674 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | LYRM7 ATXN2L MYO7A PSMA7 RPS18 HNRNPA2B1 DDX1 EHD4 MDN1 SNX6 MIEF1 KIF5A PLEC NME1 NME2 HSPA1L HSPA2 IMMT HSPA6 KPNA1 BRWD1 NOP56 PPP4R3A PPP2R1A SLC4A1AP SMC3 MRPS26 MACF1 RPL13 | 8.82e-10 | 847 | 311 | 29 | 35235311 |
| Pubmed | ATXN2L FRMPD4 SYN3 RPS18 MCCC1 NDUFA9 NDUFS1 RYR2 EIF3CL CDKL5 TNRC18 GLYR1 MAP7D2 KIF2A PLEC NME1 GCN1 HSPA2 ADGRL3 WARS1 HCN4 KALRN MYO18A RICTOR ZNFX1 ZDBF2 TACC2 MIB2 SORBS1 KCTD10 UBR3 MACF1 RPL13 HDLBP | 1.01e-09 | 1139 | 311 | 34 | 36417873 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | INTS1 RPS18 HNRNPA2B1 NDUFS1 DDX1 DST DDX50 SACS GLYR1 KIF2A PLEC NME1 GCN1 HSPA6 COG4 NOP56 SFSWAP KALRN NSD2 POLDIP3 MYO18A CHD9 SARNP OXA1L NOP14 TRIM32 KCTD10 MACF1 CTBP1 IK SRRM2 AGRN RPL13 | 1.07e-09 | 1082 | 311 | 33 | 38697112 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ATXN2L RPS18 HNRNPA2B1 TERF2IP DDX1 URB1 MDN1 DDX50 GLYR1 DNAJC9 KIF2A GCN1 NOP56 NSD2 POLDIP3 POLE MYO18A FARSB TACC2 SIN3A SARNP NOP14 SMC3 EIF2B1 MACF1 IK RPL13 | 1.53e-09 | 759 | 311 | 27 | 35915203 |
| Pubmed | ATRX INTS1 CHD1 UNC45A NDUFA9 EZH2 NDUFS1 TERF2IP URB1 DST MDN1 DDX50 CCDC47 GORAB DNAJC9 KIF2A NME2 MBD4 IMMT HSPA6 KPNA1 FAM184A SFSWAP NSD2 FARSB RICTOR NOP14 SLC4A1AP TRIM32 ZBED6 ANKRD11 MACF1 CTBP1 IK MICU2 AGRN MAN1B1 HDLBP CDK7 | 2.57e-09 | 1497 | 311 | 39 | 31527615 | |
| Pubmed | MYO7A ACOT13 RPS18 AKR1C4 EZH2 HNRNPA2B1 NDUFS1 DDX1 EHD4 DNAJC9 PLEC AMOTL2 NME2 GCN1 IMMT HSPA6 WARS1 NOP56 DCPS FARSB PPP3CA SMC3 EIF2B1 AGRN RPL13 MAP3K2 HDLBP | 5.06e-09 | 803 | 311 | 27 | 36517590 | |
| Pubmed | ATXN2L PSMA7 RPS18 CHD1 HNRNPA2B1 DDX1 DDX50 GLYR1 DNAJC9 KIF5A FGR HSPA1L HSPA2 IMMT HSPA6 HSPA7 KPNA1 WASHC4 NOP56 POLDIP3 FARSB CHD9 PPP2R1A NOP14 SMC3 EIF2B1 MRPS26 MACF1 LYN FBXO21 HCK RPL13 CDK6 | 5.08e-09 | 1153 | 311 | 33 | 29845934 | |
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 10393440 | ||
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 6.27e-09 | 4 | 311 | 4 | 31479646 | |
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 10702227 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 17442338 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 28329705 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 16511129 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 15222881 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 10526179 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 21521174 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 8274401 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 6.27e-09 | 4 | 311 | 4 | 34590152 | |
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 6.27e-09 | 4 | 311 | 4 | 10500239 | |
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 6.27e-09 | 4 | 311 | 4 | 14967952 | |
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 6.27e-09 | 4 | 311 | 4 | 15193432 | |
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 16191478 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 15577209 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 6.27e-09 | 4 | 311 | 4 | 29764944 | |
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 17888864 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 19237748 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 28259989 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 7789999 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 6.27e-09 | 4 | 311 | 4 | 16508162 | |
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 17629694 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 16018803 | ||
| Pubmed | 6.27e-09 | 4 | 311 | 4 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 6.27e-09 | 4 | 311 | 4 | 18667791 | |
| Pubmed | DDX19B ATXN2L ABCF3 INTS1 RPS18 NCAPH2 ITGA1 HNRNPA2B1 DDX1 EHD4 ACSL1 MDN1 DDX50 CCDC47 MAP3K11 KIF2A KIF5A NME1 GCN1 HSPA2 IMMT GOLGA3 FERMT3 NOP56 GTSE1 MYO18A CHSY1 FARSB LRRC8D NOP14 CHTF18 MAN1B1 RPL13 | 6.95e-09 | 1168 | 311 | 33 | 19946888 | |
| Pubmed | DDX19B ATXN2L ABCF3 RPS18 UNC45A HNRNPA2B1 NDUFS1 DDX1 TNRC18 KIF2A AMOTL2 NME1 NME2 GCN1 IMMT POLDIP3 NUP98 FARSB CHD9 HDAC7 PPP2R1A OXA1L NUDT4 SMC3 INF2 WDR87 CHTF18 MRPS26 CTBP1 IK LYN SRRM2 RPL13 HDLBP | 9.74e-09 | 1247 | 311 | 34 | 27684187 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DDX19B PSMA7 INTS1 RPS18 UNC45A NDUFA9 HNRNPA2B1 NDUFS1 DDX1 EIF3CL ACSL1 URB1 MDN1 CCDC47 NME1 NME2 GCN1 HSPA2 IMMT HSPA6 KPNA1 WARS1 POLE SHMT1 FARSB PPP2R1A OXA1L PPP3CA SMC3 TRIM32 CHTF18 CTBP1 IK RPL13 | 1.18e-08 | 1257 | 311 | 34 | 37317656 |
| Pubmed | ATRX PSMA7 INTS1 CHD1 UNC45A AKR1C1 AKR1C2 DDX1 MDN1 UBN1 DNAJC9 PLEC MBD4 IMMT NSD2 POLDIP3 POLE NUP98 FARSB CHD9 SIN3A SARNP PPP4R3A PPP2R1A SMC3 EIF2B1 CHTF18 AKR1C3 IK CDK7 | 1.27e-08 | 1014 | 311 | 30 | 32416067 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ATXN2L PSMA7 RPS18 HNRNPA2B1 NDUFS1 DST PLEC NME1 NME2 HSPA1L GCN1 HSPA2 HSPA6 FARSB PPP2R1A SMC3 TRIM32 SRRM2 RPL13 HDLBP | 1.51e-08 | 477 | 311 | 20 | 31300519 |
| Pubmed | ATRX CHD1 NCAPH2 NDUFA9 TERF2IP MDN1 UBN1 KIF2A POLDIP3 GTSE1 CHD9 NOP14 SMC3 IK | 1.57e-08 | 222 | 311 | 14 | 37071664 | |
| Pubmed | NCKAP5 DST SYNJ2 MAP3K11 KIF5A PLEC CPLANE1 GCN1 COG4 NUP98 MYO18A SORBS1 PPP4R3A SMC3 ATF7IP MACF1 HCK MAP3K2 HDLBP SOS1 | 2.05e-08 | 486 | 311 | 20 | 20936779 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | SPTA1 PSMA7 DAPK1 MCCC1 NDUFA9 AKR1C1 HNRNPA2B1 AKR1C2 DDX1 DST MDN1 PLEC NME1 HSPA1L GCN1 HSPA2 IMMT WARS1 NOP56 DYNC2H1 AP1M2 RICTOR PPP2R1A AKR1C3 MACF1 HDLBP | 2.32e-08 | 807 | 311 | 26 | 30575818 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATRX ACOT13 PSMA7 RPS18 CHD1 UNC45A HNRNPA2B1 NDUFS1 DDX1 EIF3CL EHD4 URB1 MDN1 DDX50 CCDC47 GLYR1 DNAJC9 KIF2A GCN1 IMMT WARS1 NOP56 DYNC2H1 NSD2 POLDIP3 POLE NUP98 FARSB PPP2R1A NUDT4 SMC3 EIF2B1 IK SRRM2 RPL13 HDLBP | 2.43e-08 | 1425 | 311 | 36 | 30948266 |
| Pubmed | 3.11e-08 | 5 | 311 | 4 | 7737980 | ||
| Pubmed | 3.11e-08 | 5 | 311 | 4 | 38788959 | ||
| Pubmed | 3.11e-08 | 5 | 311 | 4 | 18003893 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 3.11e-08 | 5 | 311 | 4 | 21851338 | |
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 3.11e-08 | 5 | 311 | 4 | 16984997 | |
| Pubmed | 3.11e-08 | 5 | 311 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 3.11e-08 | 5 | 311 | 4 | 17064890 | |
| Pubmed | 3.11e-08 | 5 | 311 | 4 | 10672042 | ||
| Pubmed | ATXN2L INTS1 CHD1 NDUFS1 URB1 DST MDN1 GLYR1 PLEC GCN1 HSPA2 IMMT WARS1 NSD2 POLDIP3 POLE NUP98 PPP2R1A NOP14 MACF1 IK SRRM2 HDLBP | 3.13e-08 | 653 | 311 | 23 | 22586326 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DDX19B ABCF3 PSMA7 BCAT1 UNC13D RPS18 UNC45A HNRNPA2B1 TERF2IP DDX1 EIF3CL EHD4 SNX6 PLEC NME1 HSPA1L GCN1 HSPA6 KPNA1 WARS1 WASHC4 DCPS NUP98 IKBKG SHMT1 FARSB CC2D1B SCLY SARNP PPP4R3A PPP2R1A PPP3CA MACF1 HERC4 RPL13 HDLBP | 4.09e-08 | 1455 | 311 | 36 | 22863883 |
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 4.17e-08 | 12 | 311 | 5 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 4.17e-08 | 12 | 311 | 5 | 28893949 | |
| Pubmed | 4.17e-08 | 12 | 311 | 5 | 25774556 | ||
| Pubmed | FRMPD4 MYO7A PSMA7 RPS18 PFKFB2 HNRNPA2B1 NDUFS1 DST DDX50 HSPA1L HSPA2 IMMT HSPA6 NOP56 NUP98 LGSN DNAAF2 CMTM1 SRRM2 ALPK2 | 4.97e-08 | 513 | 311 | 20 | 25798074 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ATXN2L PSMA7 RPS18 UNC45A HNRNPA2B1 DDX1 EIF3CL DST MDN1 SNX6 DNAJC9 PLEC NME1 NME2 HSPA1L GCN1 HSPA2 HSPA6 KPNA1 WARS1 NOP56 MYO18A SHMT1 FARSB SARNP PPP2R1A SMC3 MACF1 SRRM2 RPL13 HDLBP | 5.78e-08 | 1149 | 311 | 31 | 35446349 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ABCF3 PSMA7 RPS18 CHD1 UNC45A NDUFA9 HNRNPA2B1 DDX1 CCDC47 DNAJC9 KIF2A PLEC NME1 GCN1 IMMT HSPA6 KPNA1 NOP56 FARSB TACC2 SIN3A TRAPPC2B LRRC8D PPP2R1A OXA1L SLC4A1AP SMC3 CHTF18 MRPS26 MACF1 IK SRRM2 MAN1B1 RPL13 HDLBP | 6.45e-08 | 1415 | 311 | 35 | 28515276 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ATRX NCAPH2 HNRNPA2B1 DDX1 EHD4 MDN1 KIF2A PLEC GCN1 FARSB SIN3A PPP2R1A SMC3 ATF7IP SRRM2 HDLBP | 6.49e-08 | 332 | 311 | 16 | 32786267 |
| Pubmed | 7.48e-08 | 25 | 311 | 6 | 26098214 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DDX19B ABCF3 ATRX INTS1 UNC45A HNRNPA2B1 DDX1 EHD4 MDN1 UBN1 PLEC GCN1 HSPA6 KPNA1 POLE PPP2R1A SMC3 MACF1 IK SRRM2 HDLBP | 8.45e-08 | 582 | 311 | 21 | 20467437 |
| Pubmed | 9.28e-08 | 6 | 311 | 4 | 19273550 | ||
| Pubmed | 9.28e-08 | 6 | 311 | 4 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 9.28e-08 | 6 | 311 | 4 | 26748576 | |
| Pubmed | 9.28e-08 | 6 | 311 | 4 | 17122075 | ||
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 9.28e-08 | 6 | 311 | 4 | 29107092 | |
| Pubmed | 9.28e-08 | 6 | 311 | 4 | 15860270 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 9.28e-08 | 6 | 311 | 4 | 17255200 | |
| Pubmed | RALGAPA1 ATXN2L ATRX PSMA7 RPS18 CHD1 HNRNPA2B1 DDX1 CAPN8 DST MDN1 STOML3 IKBKG SARNP HDAC7 PPP3CA SMC3 CHTF18 MACF1 RPL13 | 1.07e-07 | 538 | 311 | 20 | 28524877 | |
| Pubmed | ATXN2L SYN3 SNX17 EIF3CL DST SACS PLEC ADGRL3 RASGRF1 MYO18A NRG2 SORBS1 PPP3CA MACF1 SRRM2 SOS1 | 1.19e-07 | 347 | 311 | 16 | 17114649 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | ATRX INTS1 EZH2 HNRNPA2B1 DDX1 MDN1 DDX50 GLYR1 DNAJC9 KPNA1 NOP56 POLDIP3 CHD9 SIN3A PPP2R1A KIF18B MICU2 | 1.23e-07 | 394 | 311 | 17 | 27248496 |
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 1.23e-07 | 27 | 311 | 6 | 14581517 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ATXN2L RPS18 UNC45A NDUFA9 HNRNPA2B1 DDX1 EIF3CL DST DDX50 GLYR1 DNAJC9 KIF2A PLEC IMMT KPNA1 NOP56 POLDIP3 NUP98 MYO18A FARSB PPP2R1A NOP14 SMC3 MRPS26 KCTD10 STON2 IK MICU2 LYN RPL13 HDLBP CDK7 | 1.30e-07 | 1257 | 311 | 32 | 36526897 |
| Pubmed | TET2 ATXN2L RPS18 CHD1 HNRNPA2B1 NDUFS1 TNRC18 DDX50 PLEC GCN1 IMMT NOP56 POLDIP3 NUP98 SIN3A PPP4R3A PPP2R1A OXA1L SRRM2 FBXO21 RPL13 MAP3K2 | 1.43e-07 | 655 | 311 | 22 | 35819319 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L ATRX EZH2 HNRNPA2B1 TERF2IP EIF3CL MYO3A MDN1 UBN1 PLEC SFSWAP GTSE1 NUP98 MYO18A RICTOR SIN3A HDAC7 PPP4R3A SLC4A1AP CHTF18 PKN1 SRRM2 HDLBP SOS1 | 1.65e-07 | 774 | 311 | 24 | 15302935 |
| Pubmed | 2.15e-07 | 7 | 311 | 4 | 33127481 | ||
| Pubmed | 2.15e-07 | 7 | 311 | 4 | 12562828 | ||
| Pubmed | 2.15e-07 | 7 | 311 | 4 | 22529366 | ||
| Pubmed | 2.15e-07 | 7 | 311 | 4 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 2.15e-07 | 7 | 311 | 4 | 34843575 | |
| Pubmed | 2.15e-07 | 7 | 311 | 4 | 16337335 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ATRX SPTA1 INTS1 RPS18 NCAPH2 MCCC1 EZH2 HNRNPA2B1 TERF2IP URB1 DST MDN1 UBN1 DDX50 GLYR1 DNAJC9 MBD4 HSPA6 NOP56 SFSWAP NSD2 POLDIP3 NUP98 SIN3A MBIP THAP4 PPP2R1A ANKRD11 IK KIF18B SRRM2 RPL13 | 2.47e-07 | 1294 | 311 | 32 | 30804502 |
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | TET2 GDF5 HDAC11 SYN3 NCKAP5 NME2 RAD51B MICAL1 TENT5A ZNFX1 MYO1F CDK6 | 2.60e-07 | 198 | 311 | 12 | 20881960 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 DDX19B TET2 ATXN2L PFKFB2 MCCC1 UNC45A DDX1 PLEKHG1 DST MDN1 SYNJ2 MIEF1 KIF2A PLEC ARHGAP21 GTSE1 RICTOR SORBS1 HDAC7 TRAK1 ANKRD11 MACF1 SRRM2 MAP3K2 | 3.09e-07 | 861 | 311 | 25 | 36931259 |
| Pubmed | 3.14e-07 | 17 | 311 | 5 | 32243503 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ATRX MYO7A PSMA7 NCAPH2 PFKFB2 NDUFA9 NDUFS1 DDX1 EIF3CL ACSL1 TBC1D32 CCDC154 DNAJC9 PLEC HSPA1L GCN1 IMMT CFAP91 DYNC2H1 SARNP HDAC7 PPP4R3A EFHC2 DNAAF2 PPP2R1A OXA1L SMC3 TRIM32 EIF2B1 CTBP1 KIF18B MAP3K2 | 3.89e-07 | 1321 | 311 | 32 | 27173435 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | HDAC11 TNRC18 MDN1 GCN1 KPNA1 NOP56 NUP98 SIN3A HDAC7 SMC3 ANKRD11 CTBP1 IK SRRM2 | 4.08e-07 | 289 | 311 | 14 | 23752268 |
| Interaction | AKR1C4 interactions | 3.63e-08 | 8 | 297 | 5 | int:AKR1C4 | |
| Interaction | KCTD13 interactions | RALGAPA1 ATXN2L DENND2A HDAC11 SYN3 MYO7A SPTA1 PSMA7 DAPK1 RPS18 LRRTM1 NDUFA9 HNRNPA2B1 PTGS2 NDUFS1 DDX1 CDKL5 DST SACS MAP7D2 KIF2A PLEC HSPA1L HSPA2 IMMT ARHGAP21 GOLGA3 ACSL6 MICAL1 WARS1 KALRN MYO18A FARSB ZNFX1 SORBS1 PPP2R1A PPP3CA INF2 KCTD10 STON2 LRRCC1 MACF1 CTBP1 HCK RPL13 DNAH11 HDLBP | 8.34e-08 | 1394 | 297 | 47 | int:KCTD13 |
| Interaction | MEX3A interactions | ACER2 CAPN8 FAT1 TNRC18 DST UBN1 SACS GLYR1 MAP7D2 PLEC AMOTL2 GOLGA3 NSD2 TENT5A GTSE1 LARS2 ZBED6 ANKRD11 MACF1 ALPK2 | 1.20e-06 | 384 | 297 | 20 | int:MEX3A |
| Interaction | DSCAM interactions | ATRX DST SACS MAP3K11 KIF5A PLEC AMOTL2 COG4 CFAP91 WARS1 WASHC4 KALRN MACF1 | 1.60e-06 | 171 | 297 | 13 | int:DSCAM |
| Interaction | SNW1 interactions | DDX19B HDAC11 ABCF3 ATRX INTS1 UNC45A EZH2 HNRNPA2B1 TERF2IP DDX1 EHD4 MDN1 PLEC HSPA1L GCN1 HSPA2 HSPA6 KPNA1 POLE IKBKG SIN3A TRAK1 PPP2R1A SMC3 KCTD10 CTBP1 IK SRRM2 HDLBP | 2.17e-06 | 747 | 297 | 29 | int:SNW1 |
| Interaction | MECP2 interactions | ATXN2L ATRX INTS1 RPS18 EZH2 HNRNPA2B1 NDUFS1 DDX1 CDKL5 URB1 DST DDX50 SACS GLYR1 KIF2A PLEC NME1 GCN1 HSPA6 COG4 NOP56 SFSWAP KALRN NSD2 POLDIP3 MYO18A CHD9 SIN3A SARNP OXA1L NOP14 SMC3 TRIM32 KCTD10 MACF1 CTBP1 IK SRRM2 AGRN RPL13 CDK7 | 2.62e-06 | 1287 | 297 | 41 | int:MECP2 |
| Interaction | SMC5 interactions | ATXN2L ATRX RPS18 CHD1 MCCC1 HNRNPA2B1 DDX1 UBN1 DDX50 MANF NME1 NME2 MBD4 HSPA2 IMMT NOP56 DCPS SFSWAP NSD2 POLDIP3 GTSE1 NUP98 FARSB ZDBF2 SARNP HDAC7 SLC4A1AP SMC3 ATF7IP ANKRD11 IK KIF18B SRRM2 HDLBP | 5.20e-06 | 1000 | 297 | 34 | int:SMC5 |
| Interaction | PRC1 interactions | ATXN2L ATRX RPS18 CHD1 UNC45A NDUFA9 HNRNPA2B1 NDUFS1 DDX1 URB1 DDX50 GLYR1 CCDC154 KIF2A PLEC GCN1 IMMT HSPA7 FERMT3 NOP56 POLDIP3 NUP98 MYO18A TACC2 PPP2R1A INF2 STON2 MYO1F APOL6 IK SRRM2 FBXO21 RPL13 | 7.61e-06 | 973 | 297 | 33 | int:PRC1 |
| Interaction | PTEN interactions | ERBB3 ATRX SPTA1 MCCC1 EZH2 NDUFS1 TERF2IP DDX1 MDN1 DDX50 CCDC47 PLEC NME1 HSPA1L HSPA2 HSPA6 TRAPPC2 NOP56 NSD2 NUP98 MYO18A FARSB SIN3A CMTM1 PPP3CA SMC3 INF2 ANKRD11 CTBP1 AGRN MAN1B1 RPL13 | 7.72e-06 | 929 | 297 | 32 | int:PTEN |
| Interaction | HECTD1 interactions | ATXN2L RPS18 NCAPH2 HNRNPA2B1 TERF2IP DDX1 EHD4 URB1 MDN1 DDX50 GLYR1 DNAJC9 KIF2A GCN1 NOP56 SFSWAP NSD2 POLDIP3 POLE MYO18A AP1M2 FARSB TACC2 SIN3A SARNP NOP14 SMC3 LRRC31 EIF2B1 ANKRD11 MACF1 IK RPL13 | 9.60e-06 | 984 | 297 | 33 | int:HECTD1 |
| Interaction | SLX4 interactions | ATRX CHD1 NCAPH2 MCCC1 NDUFA9 TERF2IP MDN1 UBN1 KIF2A NME2 GCN1 HSPA6 KPNA1 POLDIP3 GTSE1 FARSB CHD9 NOP14 SMC3 ATF7IP IK RPL13 HDLBP | 1.46e-05 | 572 | 297 | 23 | int:SLX4 |
| Interaction | H1-5 interactions | DDX19B DENND2A RPS18 EZH2 EIF3CL TBC1D32 GLYR1 HSPA1L DCPS NSD2 POLDIP3 PABPC4L RICTOR ZDBF2 ACSF2 PPP4R3A SLC4A1AP WDR87 RPL13 SOS1 | 1.95e-05 | 463 | 297 | 20 | int:H1-5 |
| Interaction | YWHAE interactions | RALGAPA1 TET2 ATXN2L SYN3 HLA-DRA CCR9 PSMA7 TENT5C PFKFB2 EZH2 HNRNPA2B1 DST SYNJ2 KCNH2 COQ9 MIEF1 MAP3K15 KIF5A AMOTL2 ARHGAP21 GOLGA3 TRAPPC2 ATG101 RASGRF1 GTSE1 RICTOR TACC2 SORBS1 HDAC7 TRAK1 TRIM32 EIF2B1 MACF1 SRRM2 AGRN MAP3K2 HDLBP CDK7 | 2.02e-05 | 1256 | 297 | 38 | int:YWHAE |
| Interaction | PINK1 interactions | ATXN2L PSMA7 RPS18 HNRNPA2B1 AKR1C2 NDUFS1 EHD4 ACSL1 DST PLEC NME1 NME2 HSPA1L GCN1 HSPA2 IMMT HSPA6 FARSB RICTOR PPP2R1A SMC3 TRIM32 SRRM2 RPL13 HDLBP | 2.72e-05 | 679 | 297 | 25 | int:PINK1 |
| Interaction | TOP3B interactions | DDX19B MYO7A INTS1 UNC45A PLEKHG1 URB1 FAT1 TNRC18 DST MDN1 UBN1 KCNH2 MAP3K11 PLEC GCN1 IMMT ARHGAP21 BAHCC1 UNC13B PNPLA2 RASA3 KALRN NSD2 POLDIP3 POLE GTSE1 CHSY1 MIB2 LARS2 TEP1 HDAC7 TRAK1 MROH1 LRRC31 INF2 TTLL4 USP40 ANKRD11 PKN1 LYN AGRN HDLBP | 2.77e-05 | 1470 | 297 | 42 | int:TOP3B |
| Interaction | EEF1AKMT3 interactions | ABCF3 EHD4 MDN1 HSPA1L GCN1 HSPA2 HSPA7 WASHC4 POLE IKBKG RICTOR SMC3 CHTF18 CHEK2 GPSM1 CDK6 HDLBP | 3.12e-05 | 364 | 297 | 17 | int:EEF1AKMT3 |
| Interaction | DNAJC8 interactions | ATRX CHD1 HNRNPA2B1 TERF2IP HSPA1L NOP56 IKBKG SARNP PPP4R3A SLC4A1AP ANKRD11 SRRM2 HDLBP | 3.94e-05 | 230 | 297 | 13 | int:DNAJC8 |
| Interaction | EED interactions | ABCF3 INTS1 DAPK1 RPS18 UNC45A EZH2 HNRNPA2B1 NDUFS1 TERF2IP DDX1 URB1 DDX50 SNX6 GLYR1 PLEC IMMT KPNA1 TRAPPC2 WARS1 WASHC4 NOP56 DCPS NSD2 NUP98 MYO18A FARSB RICTOR SIN3A PPP2R1A NOP14 SMC3 STON2 MACF1 CTBP1 IK KIF18B SRRM2 AGRN MAN1B1 RPL13 HDLBP | 4.08e-05 | 1445 | 297 | 41 | int:EED |
| Interaction | TRMU interactions | 4.32e-05 | 87 | 297 | 8 | int:TRMU | |
| Interaction | HDAC1 interactions | TET2 ATRX CHD1 MCCC1 UNC45A EZH2 DDX1 TBC1D32 TNRC18 DST CCDC47 KIF2A PLEC MBD4 GCN1 HSPA6 COG4 ARHGAP21 GOLGA3 KPNA1 BAHCC1 EFCAB6 NSD2 NUP98 IKBKG ZDBF2 SIN3A MBIP HDAC7 PPP4R3A TRAK1 PPP2R1A SMC3 CTBP1 | 4.32e-05 | 1108 | 297 | 34 | int:HDAC1 |
| Interaction | CIT interactions | ATXN2L INTS1 RPS18 CHD1 EZH2 HNRNPA2B1 DDX1 EIF3CL URB1 DDX50 GLYR1 DNAJC9 KIF2A PLEC HSPA1L GCN1 HSPA2 IMMT HSPA6 HSPA7 AMPD3 NOP56 KALRN DYNC2H1 POLDIP3 NUP98 MYO18A SIN3A SARNP PPP2R1A NOP14 SMC3 LRRC31 INF2 KCTD10 MACF1 IK SRRM2 FBXO21 RPL13 HDLBP | 4.41e-05 | 1450 | 297 | 41 | int:CIT |
| Interaction | YWHAQ interactions | RALGAPA1 TET2 ATXN2L PDE6C SPTA1 DAPK1 PFKFB2 MCCC1 EZH2 HNRNPA2B1 DDX1 DST SYNJ2 MIEF1 KIF5A PLEC FGR AMOTL2 NME1 GCN1 ARHGAP21 TRAPPC2 DCPS GTSE1 RICTOR SORBS1 LARS2 HDAC7 TRAK1 TH TRIM32 MACF1 MAP3K2 CDK7 | 5.16e-05 | 1118 | 297 | 34 | int:YWHAQ |
| Interaction | PML interactions | TET2 HDAC11 ABCF3 ATRX SPTA1 EZH2 NDUFS1 TERF2IP ACSL1 MDN1 UBN1 DDX50 GCN1 HSPA6 DCPS GTSE1 TACC2 SIN3A HDAC7 PPP2R1A SLC4A1AP ATF7IP CHTF18 CHEK2 IK MAN1B1 RPL13 CDK6 HDLBP CDK7 | 5.42e-05 | 933 | 297 | 30 | int:PML |
| Interaction | NEK4 interactions | FRMPD4 MYO7A HLA-DRA PSMA7 RPS18 PFKFB2 HNRNPA2B1 NDUFS1 DST DDX50 HSPA1L HSPA2 IMMT HSPA6 NOP56 NUP98 LGSN DNAAF2 CMTM1 SMC3 SRRM2 ALPK2 | 5.67e-05 | 582 | 297 | 22 | int:NEK4 |
| Interaction | CDC5L interactions | DDX19B TET2 ABCF3 INTS1 UNC45A HNRNPA2B1 EHD4 DST MDN1 UBN1 PLEC HSPA1L GCN1 HSPA2 HSPA6 PURG KALRN RICTOR ZDBF2 TRAK1 PPP2R1A NOP14 SMC3 MACF1 IK SRRM2 RPL13 HDLBP | 7.11e-05 | 855 | 297 | 28 | int:CDC5L |
| Interaction | PRODH interactions | 7.32e-05 | 16 | 297 | 4 | int:PRODH | |
| Interaction | MARK3 interactions | DAPK1 DDX1 KIF2A TRAPPC2 PNPLA2 RASGRF1 POLDIP3 HDAC7 PPP2R1A MACF1 LYN MAP3K2 HDLBP | 7.84e-05 | 246 | 297 | 13 | int:MARK3 |
| Interaction | MYCBP2 interactions | HDAC11 ERBB3 DAPK1 HNRNPA2B1 DST MDN1 KIF2A ARHGAP21 KPNA1 NSD2 SORBS1 PPP2R1A MACF1 PKN1 ALPK2 CCDC158 | 8.11e-05 | 355 | 297 | 16 | int:MYCBP2 |
| Interaction | CEP250 interactions | SPTA1 DAPK1 RPS18 SYNC GALNT18 DST HSPA1L HSPA2 HSPA7 GOLGA3 DCPS TRIM32 ATF7IP RPL13 | 9.87e-05 | 287 | 297 | 14 | int:CEP250 |
| Interaction | HAPSTR1 interactions | ATXN2L ATRX RPS18 FREM2 URB1 SNX6 KIF2A MAP3K15 NME2 CPLANE1 HSPA1L GCN1 GOLGA3 KPNA1 BRWD1 FAM184A NUP98 SHMT1 FARSB ANKH SGK2 PPP2R1A SLC4A1AP ZBED6 ZNF256 SRRM2 SOS1 | 1.05e-04 | 829 | 297 | 27 | int:HAPSTR1 |
| Interaction | ATG16L1 interactions | UNC13D HNRNPA2B1 DDX1 RYR2 RASSF5 PLEKHG1 CCDC47 MANF DNAJC9 PLEC GCN1 IMMT GOLGA3 FERMT3 ATG101 DENND5B MICAL1 WARS1 WASHC4 SFSWAP IKBKG FARSB RICTOR ANKRD50 SARNP ANKRD44 PPP2R1A SMC3 EIF2B1 KCTD10 TTLL4 IK LYN HDLBP | 1.08e-04 | 1161 | 297 | 34 | int:ATG16L1 |
| Interaction | H2BC9 interactions | LYRM7 ATRX DAPK1 EZH2 HNRNPA2B1 TNRC18 DST SYNJ2 MAP7D2 KIF5A HSPA7 AMPD3 POLDIP3 NUP98 CC2D1B SLITRK3 TEP1 SMC3 | 1.20e-04 | 446 | 297 | 18 | int:H2BC9 |
| Interaction | AGR2 interactions | SPTA1 PSMA7 DAPK1 MCCC1 NDUFA9 AKR1C1 HNRNPA2B1 AKR1C2 DDX1 DST MDN1 PLEC NME1 HSPA1L GCN1 HSPA2 IMMT WARS1 NOP56 DYNC2H1 AP1M2 RICTOR PPP2R1A ANKRD11 AKR1C3 MACF1 AGRN HCK HDLBP | 1.33e-04 | 934 | 297 | 29 | int:AGR2 |
| Interaction | ACTA1 interactions | TET2 ERBB3 MYO7A SPTA1 MTSS1 HLX DST PLEC DCPS MYO18A MIB2 SORBS1 TRIM32 MACF1 AGRN CDK7 | 1.35e-04 | 371 | 297 | 16 | int:ACTA1 |
| Interaction | KIF23 interactions | ATXN2L RPS18 CHD1 NDUFA9 HNRNPA2B1 TERF2IP DDX1 TNRC18 DDX50 PLEC GCN1 IMMT HSPA7 ARHGAP21 MICAL1 NOP56 IKBKG CHD9 PABPC4L RICTOR NOP14 INF2 TRIM32 KCTD10 MYO1F MACF1 LRRC8B LYN SRRM2 FBXO21 RPL13 | 1.38e-04 | 1031 | 297 | 31 | int:KIF23 |
| Interaction | RPS6KB2 interactions | GDF5 RPS18 HNRNPA2B1 DDX1 CCDC47 KIF2A HSPA6 POLDIP3 IKBKG SGK2 PPP2R1A LYN RPL13 | 1.42e-04 | 261 | 297 | 13 | int:RPS6KB2 |
| Interaction | KDM1A interactions | TET2 HDAC11 BCAT1 MCCC1 UNC45A NDUFA9 EZH2 NDUFS1 TERF2IP DDX1 DST GLYR1 PLEC MBD4 GCN1 IMMT HSPA6 ARHGAP21 GOLGA3 NSD2 IKBKG ZDBF2 SIN3A KASH5 SLC4A1AP ATF7IP CTBP1 IK MTMR9 | 1.51e-04 | 941 | 297 | 29 | int:KDM1A |
| Interaction | TMPO interactions | ATXN2L HDAC11 ATRX RPS18 CHD1 NDUFS1 DDX1 CCDC47 GCN1 IMMT HSPA6 GOLGA3 DCPS NSD2 NUP98 MYO18A RICTOR ZDBF2 TACC2 LRRC31 INF2 SRRM2 RPL13 HDLBP CDK7 | 1.70e-04 | 762 | 297 | 25 | int:TMPO |
| Interaction | HTT interactions | ATXN2L SPTA1 PSMA7 MTSS1 RPS18 CHD1 MCCC1 NDUFA9 EZH2 HNRNPA2B1 NDUFS1 ACSL1 DST KIF2A PLEC MBD4 HSPA2 IMMT GPD1 ACSL6 MYO18A IKBKG SIN3A PPP3CA CTBP1 LYN HCK RPL13 HDLBP | 1.74e-04 | 949 | 297 | 29 | int:HTT |
| Interaction | OBSL1 interactions | PSMA7 CHD1 EZH2 HNRNPA2B1 DDX1 URB1 DST MDN1 DDX50 GLYR1 DNAJC9 KIF2A PLEC GCN1 IMMT GOLGA3 NOP56 POLDIP3 NUP98 PPP4R3A PPP2R1A SMC3 MACF1 IK SRRM2 ALPK2 RPL13 HDLBP | 1.75e-04 | 902 | 297 | 28 | int:OBSL1 |
| Interaction | TNIK interactions | CDKL5 DST SNX6 KIF2A KIF5A ARHGAP21 NOP56 KALRN ANKRD50 PPP2R1A MACF1 CTBP1 LYN AGRN HDLBP SOS1 | 1.83e-04 | 381 | 297 | 16 | int:TNIK |
| Interaction | AKR1C1 interactions | 1.86e-04 | 20 | 297 | 4 | int:AKR1C1 | |
| Interaction | CIB2 interactions | 1.93e-04 | 81 | 297 | 7 | int:CIB2 | |
| Interaction | SUMO2 interactions | ATRX NCAPH2 EZH2 HNRNPA2B1 DDX1 EHD4 DST MDN1 KIF2A PLEC GCN1 KALRN FARSB SIN3A PPP2R1A SMC3 ATF7IP KIF18B SRRM2 HDLBP CDK7 | 1.97e-04 | 591 | 297 | 21 | int:SUMO2 |
| Interaction | AKR1C3 interactions | 1.99e-04 | 37 | 297 | 5 | int:AKR1C3 | |
| Cytoband | 10p15-p14 | 6.07e-06 | 6 | 311 | 3 | 10p15-p14 | |
| GeneFamily | Aldo-keto reductases | 1.99e-05 | 15 | 205 | 4 | 399 | |
| GeneFamily | Heat shock 70kDa proteins | 3.40e-05 | 17 | 205 | 4 | 583 | |
| GeneFamily | EF-hand domain containing|Plakins | 7.71e-05 | 8 | 205 | 3 | 939 | |
| GeneFamily | EF-hand domain containing | 2.06e-04 | 219 | 205 | 10 | 863 | |
| GeneFamily | UNC13 homologs | 7.56e-04 | 4 | 205 | 2 | 836 | |
| GeneFamily | Potassium voltage-gated channels | 1.07e-03 | 40 | 205 | 4 | 274 | |
| GeneFamily | Volume regulated anion channel subunits | 1.25e-03 | 5 | 205 | 2 | 1158 | |
| GeneFamily | DEAD-box helicases | 1.28e-03 | 42 | 205 | 4 | 499 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 2.15e-03 | 23 | 205 | 3 | 523 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 2.44e-03 | 24 | 205 | 3 | 654 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.46e-03 | 50 | 205 | 4 | 1293 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 2.59e-03 | 7 | 205 | 2 | 570 | |
| GeneFamily | Cyclin dependent kinases | 3.08e-03 | 26 | 205 | 3 | 496 | |
| GeneFamily | Acyl-CoA synthetase family | 3.08e-03 | 26 | 205 | 3 | 40 | |
| GeneFamily | NME/NM23 family | 4.37e-03 | 9 | 205 | 2 | 961 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ABCA3 FRMPD4 SYN3 ATRX MYO7A MTSS1 ANO5 AKR1C1 AKR1C2 TERF2IP RYR2 EHD4 TBC1D32 MDN1 KCNC1 MAP7D2 SYT4 GOLGA3 ADGRL3 BRWD1 ACSL6 FAM184A RICTOR SORBS1 SIN3A SGK2 EFHC2 ANKRD44 DCLK3 CHSY3 HS6ST3 MAP3K2 | 2.46e-06 | 1106 | 306 | 32 | M39071 |
| Coexpression | BENPORATH_PRC2_TARGETS | TET2 FRMPD4 HLX LRRTM1 GALNT18 PTHLH PGM5 RASSF5 PLEC HSPA6 ADGRL3 NPAS1 CFAP91 RASGRF1 POLE NRG2 POU3F4 SLITRK3 POU4F1 POU4F2 KCNV1 SLCO2A1 HS6ST3 | 2.81e-06 | 650 | 306 | 23 | M8448 |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_MYELOID | 5.74e-06 | 139 | 306 | 10 | M39044 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_UP | 2.20e-05 | 197 | 306 | 11 | M9917 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP | ABCA3 MCCC1 EZH2 SYNJ2 CCDC47 FGR IMMT PURG WARS1 SMC3 HERC4 | 2.30e-05 | 198 | 306 | 11 | M7046 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 2.35e-05 | 30 | 306 | 5 | MM853 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_UP | MTSS1 PTGS2 KIF5A AMOTL2 GPD1 PNPLA2 WNT9A PTGES KCNK10 MAN1B1 MAP3K2 | 2.52e-05 | 200 | 306 | 11 | M7754 |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | ACER2 DDX1 CAPN8 MBD4 DYNC2H1 AP1M2 TACC2 LRIG3 SMC3 ZBED6 CDK6 | 2.52e-05 | 200 | 306 | 11 | M9188 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | FRMPD4 SYN3 MTSS1 ANO5 AKR1C1 AKR1C2 TERF2IP RYR2 RASSF5 CDKL5 TBC1D32 URB1 KCNC1 MAP7D2 SYT4 ACSL6 NRG2 CCDC39 ANKRD44 APOL6 GPSM1 HS6ST3 | 3.09e-05 | 703 | 306 | 22 | M39070 |
| Coexpression | BENPORATH_SUZ12_TARGETS | TET2 FRMPD4 CYP2J2 HLX TENT5C LRRTM1 GALNT18 PTHLH PGM5 RASSF5 MAP7D2 PLEC HSPA6 ADGRL3 NPAS1 CFAP91 RASGRF1 HCN4 POLE NRG2 POU3F4 SLITRK3 POU4F1 POU4F2 KCNV1 SLCO2A1 ANKRD11 HS6ST3 | 3.60e-05 | 1035 | 306 | 28 | M9898 |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 3.85e-05 | 17 | 306 | 4 | MM826 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 4.91e-05 | 111 | 306 | 8 | MM705 | |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | MTSS1 DAPK1 URB1 BRWD1 AMPD3 NOP56 SIN3A ANKRD44 ANKRD11 MAP3K2 | 5.66e-05 | 181 | 306 | 10 | M6849 |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | BCAT1 PFKFB2 AKR1C1 HNRNPA2B1 PTHLH RASSF5 FAT1 DST PLEC AMOTL2 NME1 NME2 MBD4 ARHGAP21 KPNA1 WNT9A PTGES IKBKG CHD9 SIN3A PPP3CA TRIM32 STON2 MAN1B1 | 6.04e-05 | 843 | 306 | 24 | M2356 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | LYRM7 ACOT13 BCAT1 NCAPH2 NDUFA9 EZH2 NDUFS1 DDX1 UBN1 GLYR1 COQ9 MANF DNAJC9 NME1 IMMT BAHCC1 SNRNP25 DCPS NSD2 POLE TTI2 GTSE1 SHMT1 FARSB SARNP SLC4A1AP EIF2B1 CHTF18 CHEK2 LRRCC1 CTBP1 KIF18B HDLBP | 6.38e-05 | 1363 | 306 | 33 | M45782 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 ATXN2L ATRX MYO7A PSMA7 UNC13D RPS18 CHD1 ITGA1 HNRNPA2B1 TERF2IP RASSF5 SACS KIF2A FERMT3 BRWD1 MICAL1 NUP98 CHSY1 RICTOR ZNFX1 SIN3A PPP4R3A ANKRD44 SMC3 ATF7IP MYO1F ANKRD11 MACF1 CTBP1 IK MTMR9 RPL13 MAP3K2 SOS1 | 7.12e-05 | 1492 | 306 | 35 | M40023 |
| Coexpression | GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN | RALGAPA1 TOGARAM1 MAP3K11 SYT4 NSD2 TBPL1 WNT9A ANKH ANKRD44 KCTD10 | 1.19e-04 | 198 | 306 | 10 | M9346 |
| Coexpression | GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN | BCAT1 IMMT ATG101 NOP56 RASA3 HCN4 IKBKG CC2D1B PPP2R1A AGRN | 1.19e-04 | 198 | 306 | 10 | M3130 |
| Coexpression | GSE11924_TFH_VS_TH17_CD4_TCELL_UP | ERBB3 COG4 BRWD1 AMPD3 PNPLA2 CC2D1B ZNFX1 ZBED6 FHDC1 MAN1B1 | 1.24e-04 | 199 | 306 | 10 | M3156 |
| Coexpression | ALFANO_MYC_TARGETS | ABCA3 ITGA7 MDN1 KCNH2 PLEC HSPA1L NPAS1 NOP56 TACC2 EIF2B1 AGRN | 1.26e-04 | 239 | 306 | 11 | M2477 |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | TET2 FRMPD4 CYP2J2 TTLL9 HLX LRRTM1 GALNT18 PTHLH PGM5 RASSF5 PLEC HSPA1L HSPA6 ADGRL3 NPAS1 CFAP91 RASGRF1 HCN4 POLE NRG2 POU3F4 SLITRK3 POU4F1 POU4F2 KCNV1 SLCO2A1 DDX25 HS6ST3 | 1.28e-04 | 1115 | 306 | 28 | M10371 |
| Coexpression | GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN | 1.30e-04 | 200 | 306 | 10 | M8056 | |
| Coexpression | GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN | F10 PLEKHG1 FREM2 FGR BRWD1 DYNC2H1 IKBKG ANKRD50 LRRC8D AKR1C3 | 1.30e-04 | 200 | 306 | 10 | M8076 |
| Coexpression | GSE11924_TFH_VS_TH2_CD4_TCELL_UP | UNC45A SACS SYNJ2 MAP3K11 COG4 CC2D1B HDAC7 ZBED6 ATF7IP SRRM2 | 1.30e-04 | 200 | 306 | 10 | M3153 |
| Coexpression | DESCARTES_ORGANOGENESIS_EPENDYMAL_CELL | FRMPD4 TTLL9 STOX1 PTHLH ENO4 CFAP47 CFAP91 EFCAB6 WNT9A CCDC39 EFHC2 PCP4L1 | 1.31e-04 | 282 | 306 | 12 | MM3642 |
| Coexpression | BENPORATH_EED_TARGETS | TET2 FRMPD4 MTSS1 HLX LRRTM1 GALNT18 PTHLH PGM5 RASSF5 MAP7D2 PLEC HSPA1L HSPA6 ADGRL3 NPAS1 CFAP91 RASGRF1 POLE NRG2 POU3F4 SLITRK3 POU4F1 POU4F2 KCNV1 SLCO2A1 SRRM2 HS6ST3 | 1.33e-04 | 1059 | 306 | 27 | M7617 |
| Coexpression | MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP | MTSS1 DAO AKR1C1 KCNH2 C3AR1 KIF5A HSPA6 ACSL6 FMO2 NOP56 PTGES EFHC2 INF2 KCNK10 | 1.51e-04 | 376 | 306 | 14 | M19025 |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 1.56e-04 | 69 | 306 | 6 | MM621 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 1.61e-04 | 24 | 306 | 4 | MM766 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 SPTA1 ANO5 COL22A1 RYR2 CAPN8 FREM2 FAT1 KIF5A ADGRL3 EFCAB6 KALRN DNAH11 | 6.18e-10 | 184 | 310 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 SPTA1 ANO5 COL22A1 RYR2 CAPN8 FREM2 FAT1 KIF5A ADGRL3 EFCAB6 KALRN DNAH11 | 6.18e-10 | 184 | 310 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 SPTA1 ANO5 COL22A1 RYR2 CAPN8 FREM2 FAT1 KIF5A ADGRL3 EFCAB6 KALRN DNAH11 | 6.18e-10 | 184 | 310 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ABCA3 PFKFB2 FREM2 UNC13B CFAP47 FAM184A CFAP91 DYNC2H1 TACC2 CCDC39 FHDC1 DNAH11 | 1.20e-08 | 193 | 310 | 12 | bdb7401dd9059032f930f2b575f2ef8e504b6594 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | RALGAPA1 CHD1 ITGA1 HNRNPA2B1 RICTOR ANKRD44 ZBED6 ATF7IP ANKRD11 MACF1 MAP3K2 | 9.11e-08 | 188 | 310 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ABCA3 TCIM MCCC1 CAPN8 FREM2 UNC13B FAM184A RASGRF1 TACC2 MBIP FHDC1 | 1.19e-07 | 193 | 310 | 11 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ABCA3 TCIM MCCC1 CAPN8 FREM2 UNC13B FAM184A RASGRF1 TACC2 MBIP FHDC1 | 1.19e-07 | 193 | 310 | 11 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ERBB3 CYP2J2 TCIM TENT5C DAPK1 RPS18 AKR1C1 PTGS2 CAPN8 FMO2 RPL13 | 1.19e-07 | 193 | 310 | 11 | 525e0de0f25f3308daf49e7d4c8774562f1f40ad |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-Secretory/RAS|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ERBB3 CYP2J2 TCIM TENT5C DAPK1 RPS18 AKR1C1 PTGS2 CAPN8 FMO2 RPL13 | 1.19e-07 | 193 | 310 | 11 | 2d18f39615043dfbff120a00f6540ffa93082c83 |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | MTSS1 PTHLH CNTN6 FAT1 AMOTL2 NPAS1 GPD1 TENT5A POU3F4 CHEK2 | 1.26e-07 | 153 | 310 | 10 | 9c6fce56300ba5053efda59a438d63a808c497c0 |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ACER2 TCIM HLX NCKAP5 ITGA1 GALNT18 EHD4 MAP3K11 SORBS1 SLCO2A1 PCP4L1 | 1.32e-07 | 195 | 310 | 11 | 52b2bbf12e5f86c493f6634697aeb23a68cc916d |
| ToppCell | Control-Myeloid-TRAM3|Control / Disease group,lineage and cell class （2021.01.30） | ACSL1 C3AR1 IFI44L NME2 FERMT3 WARS1 TENT5A ZNFX1 LYN HCK HDLBP | 1.46e-07 | 197 | 310 | 11 | 733ff40039d67e561c2ded7c9bd0b4353101741e |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | ACSL1 C3AR1 IFI44L NME2 FERMT3 WARS1 TENT5A ZNFX1 LYN HCK HDLBP | 1.46e-07 | 197 | 310 | 11 | 0f1c4a328968b32874e6ebb0803e665adcbbc450 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TTLL9 DZIP1L CPLANE1 CFAP47 FAM184A CFAP91 EFCAB6 DYNC2H1 LGSN CCDC39 DNAH11 | 1.46e-07 | 197 | 310 | 11 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | ACSL1 C3AR1 IFI44L NME2 FERMT3 WARS1 TENT5A ZNFX1 LYN HCK HDLBP | 1.46e-07 | 197 | 310 | 11 | 4416efdbd9c4ac3356a5dff2d535c2d7383376a9 |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | ACSL1 C3AR1 IFI44L NME2 FERMT3 WARS1 TENT5A ZNFX1 LYN HCK HDLBP | 1.46e-07 | 197 | 310 | 11 | aafe0cd697b0b7f0756596148e0906443fdf8ef7 |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | ACSL1 C3AR1 IFI44L NME2 FERMT3 WARS1 TENT5A ZNFX1 LYN HCK HDLBP | 1.46e-07 | 197 | 310 | 11 | e131634bc67e0bd31a938a8e8df8dc752e1d0f47 |
| ToppCell | Control_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type | ABCA3 BCAT1 DAPK1 UNC13D CNTN6 FMO2 TENT5A AP1M2 MBIP TENT5B AKR1C3 | 1.54e-07 | 198 | 310 | 11 | 532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | ATRX CHD1 CCDC47 KIF2A PPP3CA SMC3 ANKRD11 AKR1C3 LRRCC1 HDLBP SOS1 | 1.54e-07 | 198 | 310 | 11 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA3 DAPK1 MCCC1 CAPN8 CDKL5 FREM2 UNC13B FAM184A RASGRF1 TACC2 MBIP | 1.62e-07 | 199 | 310 | 11 | 725610310e5c5fd7120c0be9acb55bf152026ddd |
| ToppCell | proximal-Epithelial-Club|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | ERBB3 CYP2J2 TCIM TENT5C DAPK1 RPS18 TENT5A MBIP AGRN MSLN RPL13 | 1.62e-07 | 199 | 310 | 11 | 99d23c0373f1ae5267bb3e51c5c88c8f52559ae4 |
| ToppCell | proximal-Epithelial-Club-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | ERBB3 CYP2J2 TCIM TENT5C DAPK1 RPS18 TENT5A MBIP AGRN MSLN RPL13 | 1.62e-07 | 199 | 310 | 11 | e8b3b003b581aa001c23440a03d80da9560129b3 |
| ToppCell | proximal-3-Epithelial-Club|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | ERBB3 CYP2J2 TCIM TENT5C DAPK1 RPS18 TENT5A MBIP AGRN MSLN RPL13 | 1.62e-07 | 199 | 310 | 11 | 77dc850032746339557c844cfc1f93eb27210f22 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | TET2 ATRX CHD1 HNRNPA2B1 IFI44L ANKRD44 ATF7IP APOL6 ANKRD11 MACF1 SRRM2 | 1.70e-07 | 200 | 310 | 11 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | ABCA3 TCIM CAPN8 FREM2 UNC13B FAM184A RASGRF1 TACC2 MBIP FHDC1 | 5.67e-07 | 180 | 310 | 10 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | ERBB3 ABCA3 PFKFB2 CAPN8 RASGRF1 TACC2 MBIP KASH5 FHDC1 MSLN | 6.94e-07 | 184 | 310 | 10 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | ERBB3 ABCA3 PFKFB2 CAPN8 RASGRF1 TACC2 MBIP KASH5 FHDC1 MSLN | 6.94e-07 | 184 | 310 | 10 | 2a8338e94937686a148b5433515700ca0f674058 |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | ABCA3 TCIM CAPN8 FREM2 UNC13B FAM184A RASGRF1 TACC2 MBIP FHDC1 | 7.66e-07 | 186 | 310 | 10 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ABCA3 PFKFB2 MCCC1 CAPN8 FREM2 UNC13B FAM184A RASGRF1 TACC2 MBIP | 8.04e-07 | 187 | 310 | 10 | 5df9e1f5ca32217af255e76e6fb5afa346337811 |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 9.30e-07 | 190 | 310 | 10 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 9.30e-07 | 190 | 310 | 10 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | ABCA3 MCCC1 CAPN8 FREM2 UNC13B FAM184A RASGRF1 TACC2 MBIP FHDC1 | 9.75e-07 | 191 | 310 | 10 | a0332a4ef629510fb313ec119195c44a3f704a80 |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | CYP2J2 TENT5C DAPK1 NCKAP5 CAPN8 PLEKHG1 FAT1 RAD51B FMO2 CHSY3 | 9.75e-07 | 191 | 310 | 10 | 23776c7302cead3881b39127398f3b3e0d27885e |
| ToppCell | IPF-Myeloid-ncMonocyte|IPF / Disease state, Lineage and Cell class | 1.02e-06 | 192 | 310 | 10 | e9fb8c57d8094f70fb492909b2bec40aa5f2e5b8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ABCA3 DAPK1 PFKFB2 MCCC1 CDKL5 FREM2 UNC13B FAM184A TACC2 MBIP | 1.02e-06 | 192 | 310 | 10 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | ABCA3 PFKFB2 MCCC1 CAPN8 FREM2 UNC13B FAM184A RASGRF1 TACC2 FHDC1 | 1.02e-06 | 192 | 310 | 10 | 06013a07e3a873b1d1c0451643c528593ac32a9c |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ACER2 NCKAP5 ITGA1 GALNT18 EHD4 ADGRL3 SORBS1 LARS2 ANKRD44 SLCO2A1 | 1.02e-06 | 192 | 310 | 10 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | ABCA3 MCCC1 CAPN8 FREM2 UNC13B FAM184A RASGRF1 TACC2 MBIP FHDC1 | 1.02e-06 | 192 | 310 | 10 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DZIP1L MTSS1 STOX1 CPLANE1 CFAP47 FAM184A CFAP91 DYNC2H1 CCDC39 DNAH11 | 1.07e-06 | 193 | 310 | 10 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | Control-Fibroblasts-Vascular_smooth_muscle|Control / group, cell type (main and fine annotations) | DENND2A SYN3 ITGA1 GALNT18 RYR2 ADGRL3 FMO2 KALRN SLCO2A1 RPL13 | 1.07e-06 | 193 | 310 | 10 | 60e44aac8be0430ad35e20eb98b1b700d76a0427 |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | ABCA3 MCCC1 CAPN8 FREM2 UNC13B FAM184A RASGRF1 TACC2 MBIP FHDC1 | 1.07e-06 | 193 | 310 | 10 | 738f4f0a9ddde2432b429ab46838e353b1790589 |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DZIP1L STOX1 STOML3 CFAP47 CFAP91 EFCAB6 DYNC2H1 CCDC39 EFHC2 DNAH11 | 1.12e-06 | 194 | 310 | 10 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ERBB3 CYP2J2 TCIM AKR1C1 AKR1C2 CAPN8 FREM2 PTGES LRIG3 MSLN | 1.12e-06 | 194 | 310 | 10 | 2172d951896265243d14996eacce5aab5e14e26e |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-06 | 195 | 310 | 10 | 815ac5dacd382b11abb32011ed1c0635b0ddc779 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | TENT5C DAPK1 NCKAP5 AKR1C1 CAPN8 PLEKHG1 FAT1 RAD51B FMO2 CHSY3 | 1.18e-06 | 195 | 310 | 10 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-06 | 195 | 310 | 10 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-06 | 195 | 310 | 10 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ABCA3 TCIM PFKFB2 CDKL5 UNC13B FAM184A RASGRF1 TACC2 MBIP FHDC1 | 1.23e-06 | 196 | 310 | 10 | 82b117be41f2e7d677a42d2a5198726eeccb16d0 |
| ToppCell | facs-Lung-ENDOMUCIN-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ACER2 HLX ITGA1 GALNT18 EHD4 MAP3K11 SORBS1 SLCO2A1 KCTD10 PCP4L1 | 1.23e-06 | 196 | 310 | 10 | f6df26ab9eebae893768a4f70a064ce9f60da93c |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.23e-06 | 196 | 310 | 10 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | SYN3 TCIM NCKAP5 ITGA1 FAT1 UNC13B WARS1 SORBS1 ANKRD44 SLCO2A1 | 1.23e-06 | 196 | 310 | 10 | 8f0f72ead06abe02b575e443552eacc2151077ef |
| ToppCell | facs-Lung-ENDOMUCIN|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ACER2 HLX ITGA1 GALNT18 EHD4 MAP3K11 SORBS1 SLCO2A1 KCTD10 PCP4L1 | 1.23e-06 | 196 | 310 | 10 | 69f03546c42c942ab8ac8746167c8d44d574b4c6 |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-06 | 197 | 310 | 10 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | ASK440-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | ABCA3 TCIM PFKFB2 CAPN8 ACSL1 UNC13B RASGRF1 MBIP FHDC1 RPL13 | 1.29e-06 | 197 | 310 | 10 | 08d5bbeb77a4152af1c783bc958afcae24667767 |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.29e-06 | 197 | 310 | 10 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | TCIM NCKAP5 ITGA1 GALNT18 UNC13B WARS1 SORBS1 ANKRD44 SLCO2A1 APOL6 | 1.29e-06 | 197 | 310 | 10 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DZIP1L STOX1 STOML3 CFAP47 CFAP91 DYNC2H1 CCDC39 EFHC2 IK DNAH11 | 1.29e-06 | 197 | 310 | 10 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DZIP1L STOX1 STOML3 CFAP47 CFAP91 DYNC2H1 CCDC39 EFHC2 IK DNAH11 | 1.29e-06 | 197 | 310 | 10 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DZIP1L STOX1 STOML3 CFAP47 CFAP91 DYNC2H1 CCDC39 EFHC2 IK DNAH11 | 1.29e-06 | 197 | 310 | 10 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 |
| ToppCell | B_cells-Activate_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | HLA-DRA MTSS1 ACSL1 IFI44L FGR AMPD3 RASA3 ANKRD44 MYO1F HCK | 1.35e-06 | 198 | 310 | 10 | a663082d7fbd6db11d3d3024bbb8ba00183e19f8 |
| ToppCell | ASK428-Epithelial-Type_2|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | ERBB3 ABCA3 TCIM MCCC1 CAPN8 FAM184A RASGRF1 TENT5A MBIP FHDC1 | 1.35e-06 | 198 | 310 | 10 | ec0d1801363adb70c6a26655b79d12b438c7417d |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA3 MCCC1 CAPN8 FREM2 UNC13B FAM184A RASGRF1 TACC2 MBIP FHDC1 | 1.35e-06 | 198 | 310 | 10 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CYP2J2 DAPK1 NCKAP5 CNTN6 CAPN8 PLEKHG1 FAT1 RAD51B FMO2 CHSY3 | 1.35e-06 | 198 | 310 | 10 | 1408e02e053ad3406229bfe8189da03be6366e81 |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | ABCA3 HLA-DRA TCIM BCAT1 PFKFB2 CAPN8 ACSL1 RASGRF1 MBIP MSLN | 1.35e-06 | 198 | 310 | 10 | 85215015bb86ada0e871c413a4ecdc903a3785ca |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | TET2 CHD1 HNRNPA2B1 ACSL1 IFI44L WARS1 MYO1F APOL6 LYN SRRM2 | 1.35e-06 | 198 | 310 | 10 | 61ceb2245b6cb58e308b999a61d218c89dbc615e |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA3 MCCC1 CAPN8 FREM2 UNC13B FAM184A RASGRF1 TACC2 MBIP FHDC1 | 1.35e-06 | 198 | 310 | 10 | f948391296c261c473d339069a6d0f20ccd6f38f |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.35e-06 | 198 | 310 | 10 | c4a004f211f72f28aacbb512c6e075cbd049be53 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ITGA1 ITGA7 RYR2 PGM5 ADGRL3 KALRN SLITRK3 SORBS1 HS6ST3 DNAH11 | 1.35e-06 | 198 | 310 | 10 | c12e7511628db819a52959bb68580e27c00c2e41 |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA3 ANO5 ITGA7 RYR2 PGM5 KCNH2 SLITRK3 SORBS1 RERGL HS6ST3 | 1.35e-06 | 198 | 310 | 10 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | ABCA3 HLA-DRA TCIM BCAT1 PFKFB2 CAPN8 ACSL1 RASGRF1 MBIP MSLN | 1.35e-06 | 198 | 310 | 10 | 38349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9 |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA3 DAPK1 MCCC1 CAPN8 CDKL5 FREM2 UNC13B FAM184A TACC2 MBIP | 1.41e-06 | 199 | 310 | 10 | 5f7da3eab58ace6cddb3179a415cd839d5767958 |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA3 DAPK1 MCCC1 CAPN8 CDKL5 FREM2 UNC13B FAM184A TACC2 MBIP | 1.41e-06 | 199 | 310 | 10 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.41e-06 | 199 | 310 | 10 | 8c2ab13b5fffbab3da37041a7000d6537fc4db09 | |
| ToppCell | distal-3-Epithelial-Club|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | ERBB3 CYP2J2 LRRTM1 PTGS2 UNC13B FMO2 TENT5A AP1M2 MBIP MSLN | 1.41e-06 | 199 | 310 | 10 | 1a0c3506df2438f5be40a8ea72effe5f8ebd35c4 |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | ERBB3 ABCA3 CAPN8 FREM2 FAM184A RASGRF1 TACC2 MBIP FHDC1 MSLN | 1.41e-06 | 199 | 310 | 10 | a38a981cffa61c8444a980916de7414e689a1b63 |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.41e-06 | 199 | 310 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ABCA3 PFKFB2 MCCC1 CAPN8 FREM2 UNC13B FAM184A TACC2 MBIP FHDC1 | 1.41e-06 | 199 | 310 | 10 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA3 DAPK1 MCCC1 CAPN8 CDKL5 FREM2 UNC13B FAM184A TACC2 MBIP | 1.41e-06 | 199 | 310 | 10 | 8587bd98de7767a575088afbea07a1feb4516b9b |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A ITGA1 ITGA7 RYR2 KCNH2 KIF5A ADGRL3 GARNL3 KALRN WDR87 | 1.41e-06 | 199 | 310 | 10 | b768496381362f9a2706e0892b5a7a0db82e09ce |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Granulocytic_cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.41e-06 | 199 | 310 | 10 | 7227e6be56e9f333ee143e1418d22de32a4ca66a | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | ERBB3 ABCA3 PFKFB2 CAPN8 UNC13B FAM184A AP1M2 TACC2 MBIP MSLN | 1.48e-06 | 200 | 310 | 10 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | ERBB3 ABCA3 PFKFB2 CAPN8 UNC13B FAM184A AP1M2 TACC2 MBIP MSLN | 1.48e-06 | 200 | 310 | 10 | 40e969883bc302e8fbc6b6ab9814529dc1472902 |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | ERBB3 ABCA3 PFKFB2 CAPN8 UNC13B FAM184A AP1M2 TACC2 MBIP MSLN | 1.48e-06 | 200 | 310 | 10 | ad9cdc82a647d379abc713a56db0e11bb6494106 |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | ERBB3 ABCA3 PFKFB2 FREM2 UNC13B FAM184A RASGRF1 AP1M2 TACC2 FHDC1 | 1.48e-06 | 200 | 310 | 10 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 310 | 10 | fd1b6db3c62f5a205b769ba0e61433dae6285b67 | |
| ToppCell | Biopsy_Other_PF-Immune-Monocytes|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.48e-06 | 200 | 310 | 10 | 83bca55d48aae8885deb83e15b2684910e4c3358 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | ERBB3 ABCA3 PFKFB2 FREM2 UNC13B FAM184A RASGRF1 AP1M2 TACC2 FHDC1 | 1.48e-06 | 200 | 310 | 10 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 310 | 10 | 1592ca96c59eb053d0f0915afb337db9f3a40c91 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | ERBB3 ABCA3 PFKFB2 FREM2 UNC13B FAM184A RASGRF1 AP1M2 TACC2 FHDC1 | 1.48e-06 | 200 | 310 | 10 | c905451425d1c24773bb0ca69bcf0309b277d2f1 |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.48e-06 | 200 | 310 | 10 | 0b7573ec4e9c67c7d11dd8f5011a70bade30e930 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-06 | 164 | 310 | 9 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-06 | 164 | 310 | 9 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | facs-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 165 | 310 | 9 | 720649f330382ea2a68c64a5344160a048afb8f1 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | TTLL9 DZIP1L CPLANE1 CFAP47 CFAP91 EFCAB6 HCN4 DYNC2H1 DNAH11 | 2.97e-06 | 169 | 310 | 9 | fba841664939c771881ba97f14ef1df6635c04ff |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.11e-06 | 170 | 310 | 9 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.59e-06 | 173 | 310 | 9 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-06 | 173 | 310 | 9 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.59e-06 | 173 | 310 | 9 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.64e-06 | 130 | 310 | 8 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.77e-06 | 174 | 310 | 9 | a3f4981b10afa9d41a1c66c7f98522a8a534f82b | |
| Drug | cloxazolam | 3.20e-08 | 4 | 306 | 4 | ctd:C005522 | |
| Drug | Pregnanes | 3.20e-08 | 4 | 306 | 4 | ctd:D011278 | |
| Drug | tetralol | 3.20e-08 | 4 | 306 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 3.20e-08 | 4 | 306 | 4 | ctd:C018156 | |
| Drug | Hydroxysteroids | 1.58e-07 | 5 | 306 | 4 | ctd:D006914 | |
| Drug | NSC86000 | 1.58e-07 | 5 | 306 | 4 | CID000257630 | |
| Drug | cresolphthalein | 1.58e-07 | 5 | 306 | 4 | ctd:C010092 | |
| Drug | 3-hydroxyhexobarbital | 4.70e-07 | 6 | 306 | 4 | CID000439898 | |
| Drug | Medazepam | 4.70e-07 | 6 | 306 | 4 | ctd:D008472 | |
| Drug | 1-acenaphthenol | 7.69e-07 | 14 | 306 | 5 | CID000022750 | |
| Drug | Meclofenamic Acid | 7.69e-07 | 14 | 306 | 5 | ctd:D008469 | |
| Drug | 2-cyclohexen-1-ol | 2.15e-06 | 8 | 306 | 4 | CID000013198 | |
| Drug | Nitrazepam | 2.15e-06 | 8 | 306 | 4 | ctd:D009567 | |
| Drug | Flufenamic Acid | 2.17e-06 | 45 | 306 | 7 | ctd:D005439 | |
| Drug | Methamphetamine | RALGAPA1 ATXN2L HDAC11 PDE6C MYO7A TTLL9 ITGA1 PFKFB2 PTGS2 DST SYNJ2 MANF PLEC BRWD1 ACSL6 MICAL1 AMPD3 FMO2 HCN4 TENT5A MYO18A CC2D1B ZNFX1 TACC2 SORBS1 HDAC7 DNAAF2 ANKRD44 LRIG3 TH PPP3CA SMC3 INF2 CHTF18 TTLL4 ANKRD11 MACF1 SRRM2 GPSM1 AGRN CDK6 | 2.30e-06 | 1401 | 306 | 41 | ctd:D008694 |
| Drug | cyclopentanol | 2.40e-06 | 3 | 306 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 2.40e-06 | 3 | 306 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 2.40e-06 | 3 | 306 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 2.40e-06 | 3 | 306 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 2.40e-06 | 3 | 306 | 3 | ctd:C530610 | |
| Drug | 4-hydroxybenzoic acid | 3.82e-06 | 9 | 306 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 3.82e-06 | 9 | 306 | 4 | ctd:D004092 | |
| Drug | octyl gallate | 6.30e-06 | 10 | 306 | 4 | ctd:C016627 | |
| Drug | Dutasteride | 7.24e-06 | 21 | 306 | 5 | ctd:D000068538 | |
| Drug | tetrahydrodeoxycorticosterone | 9.52e-06 | 4 | 306 | 3 | ctd:C009413 | |
| Drug | gliquidone | 9.52e-06 | 4 | 306 | 3 | ctd:C010969 | |
| Drug | DBD-H | 9.52e-06 | 4 | 306 | 3 | CID000131382 | |
| Drug | Dihydroxydihydrobenzopyrenes | 9.80e-06 | 11 | 306 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 9.80e-06 | 11 | 306 | 4 | CID000013946 | |
| Drug | Phenolphthalein | 1.45e-05 | 12 | 306 | 4 | ctd:D020113 | |
| Drug | SB 203580; Down 200; 1uM; PC3; HT_HG-U133A | RALGAPA1 HDAC11 SCN11A NCAPH2 PLEC DENND5B NSD2 PTGES SCLY TRAK1 MAN1B1 RPL13 | 1.64e-05 | 198 | 306 | 12 | 6894_DN |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | MTSS1 TENT5C PFKFB2 ITGA7 PTHLH URB1 KIF5A DENND5B AMPD3 PNPLA2 NRG2 POU3F4 | 1.72e-05 | 199 | 306 | 12 | 6024_UP |
| Drug | DMBA-3,4-dihydrodiol | 2.08e-05 | 13 | 306 | 4 | CID000050096 | |
| Drug | flunisolide | 2.08e-05 | 13 | 306 | 4 | ctd:C007734 | |
| Drug | 5-alpha-Dihydroprogesterone | 2.88e-05 | 14 | 306 | 4 | ctd:D043582 | |
| Drug | Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; PC3; HT_HG-U133A | HDAC11 NCAPH2 ITGA1 ITGA7 PTGS2 PTHLH RYR2 GPD1 PNPLA2 PTGES PPP3CA | 2.92e-05 | 177 | 306 | 11 | 4590_UP |
| Drug | AC1L93E5 | 4.67e-05 | 6 | 306 | 3 | CID000412383 | |
| Drug | Estazolam | 4.67e-05 | 6 | 306 | 3 | ctd:D004949 | |
| Drug | Glipizide | 4.67e-05 | 6 | 306 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 4.67e-05 | 6 | 306 | 3 | ctd:C023723 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 5.41e-05 | 31 | 306 | 5 | ctd:C017228 | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A | HDAC11 PDE6C SYNC NCAPH2 CHM OR2B6 GLYR1 PNPLA2 ANKH PPP4R3A CDK6 | 6.43e-05 | 193 | 306 | 11 | 4173_DN |
| Drug | Epitiostanol [2363-58-8]; Up 200; 13uM; MCF7; HT_HG-U133A | RALGAPA1 BCAT1 KCNH2 RAD51B AMPD3 PTGES ACSF2 TTLL4 PRKACG LRRC8B SOS1 | 6.43e-05 | 193 | 306 | 11 | 4788_UP |
| Drug | butyronitrile | 6.63e-05 | 17 | 306 | 4 | CID000008008 | |
| Drug | Boldine [476-70-0]; Down 200; 12.2uM; HL60; HT_HG-U133A | ATXN2L SYNC NCAPH2 PFKFB2 SYNJ2 GLYR1 RAD51B HDAC7 DNAAF2 AGRN RPL13 | 7.73e-05 | 197 | 306 | 11 | 2148_DN |
| Drug | 4-hydroxyequilenin-o-quinone | 8.08e-05 | 7 | 306 | 3 | ctd:C117714 | |
| Drug | zomepirac | 8.08e-05 | 7 | 306 | 3 | ctd:C020549 | |
| Drug | Seneciphylline [480-81-9]; Up 200; 12uM; MCF7; HT_HG-U133A | ABCA3 MTSS1 NCAPH2 PTHLH RYR2 FGR BAHCC1 MICAL1 PNPLA2 PTGES HDAC7 | 8.09e-05 | 198 | 306 | 11 | 2797_UP |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | CCR9 TENT5C DAPK1 CHM KCNH2 C3AR1 GPD1 PTGES SORBS1 SLCO2A1 LRRC8B | 8.09e-05 | 198 | 306 | 11 | 2242_UP |
| Drug | Fusaric acid [536-69-6]; Down 200; 22.4uM; PC3; HT_HG-U133A | CYP2J2 PTGS2 IFI44L CPLANE1 COG4 BAHCC1 PNPLA2 PTGES NRG2 HDAC7 MTMR9 | 8.09e-05 | 198 | 306 | 11 | 3986_DN |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; HL60; HG-U133A | 8.46e-05 | 199 | 306 | 11 | 1738_DN | |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; PC3; HT_HG-U133A | ITGA1 PFKFB2 SYNJ2 DENND5B MICAL1 PTGES MBIP TH LRRC8B HERC4 MTMR9 | 8.85e-05 | 200 | 306 | 11 | 4475_DN |
| Drug | NADP(H | LDHAL6A CYP2J2 SPTA1 DAO SLC46A1 AKR1C4 MCCC1 AKR1C1 AKR1C2 NDUFS1 IMMT NPAS1 GPD1 FMO2 SHMT1 LGSN TH EIF2B1 AKR1C3 | 1.04e-04 | 527 | 306 | 19 | CID000000930 |
| Drug | oxcarbazepine | 1.06e-04 | 19 | 306 | 4 | ctd:C036006 | |
| Drug | NSC36919 | 1.26e-04 | 58 | 306 | 6 | CID000235496 | |
| Drug | 1,3-cyclopentanediol | 1.28e-04 | 8 | 306 | 3 | CID000100165 | |
| Drug | benzo(a)pyrene-7,8-dione | 1.31e-04 | 20 | 306 | 4 | ctd:C076588 | |
| Drug | Chrysenes | 1.31e-04 | 20 | 306 | 4 | ctd:D002911 | |
| Disease | Neoplasms, Hormone-Dependent | 1.07e-06 | 3 | 303 | 3 | C0027661 | |
| Disease | Intersex Conditions | 1.06e-05 | 5 | 303 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 1.06e-05 | 5 | 303 | 3 | C2930619 | |
| Disease | Hermaphroditism | 1.06e-05 | 5 | 303 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 1.06e-05 | 5 | 303 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 1.06e-05 | 5 | 303 | 3 | C0033804 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.44e-05 | 139 | 303 | 9 | DOID:3908 (is_implicated_in) | |
| Disease | PR interval | HLX NCKAP5 RYR2 CNTN6 FREM2 MYO3A FAT1 GORAB TESC PLEC ADGRL3 HCN4 KALRN TRAK1 MACF1 MICU2 DNAH11 | 1.68e-05 | 495 | 303 | 17 | EFO_0004462 |
| Disease | Disorders of Sex Development | 3.64e-05 | 7 | 303 | 3 | C0036875 | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 1.05e-04 | 2 | 303 | 2 | C1839840 | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate E (implicated_via_orthology) | 1.05e-04 | 2 | 303 | 2 | DOID:0110205 (implicated_via_orthology) | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 1.05e-04 | 2 | 303 | 2 | cv:C1839840 | |
| Disease | 46,XY SEX REVERSAL 8 | 1.05e-04 | 2 | 303 | 2 | 614279 | |
| Disease | brachydactyly type A2 (implicated_via_orthology) | 1.05e-04 | 2 | 303 | 2 | DOID:0110965 (implicated_via_orthology) | |
| Disease | X-linked spondyloepiphyseal dysplasia tarda (implicated_via_orthology) | 1.05e-04 | 2 | 303 | 2 | DOID:0080362 (implicated_via_orthology) | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 1.05e-04 | 2 | 303 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | Ciliopathies | 1.45e-04 | 110 | 303 | 7 | C4277690 | |
| Disease | Colorectal Neoplasms | TET2 ABCA3 CHD1 PTGS2 FAT1 NME1 NME2 POLE SLCO2A1 CHEK2 CTBP1 | 1.51e-04 | 277 | 303 | 11 | C0009404 |
| Disease | mean platelet volume | TET2 SPTA1 TENT5C DAO UNC13D ACSL1 RASSF5 UBN1 MAP3K11 KIF2A TESC PLEC FERMT3 RAD51B MICAL1 KALRN CHD9 SORBS1 SIN3A LRRC8D HDAC7 CHEK2 ANKRD11 LYN | 1.57e-04 | 1020 | 303 | 24 | EFO_0004584 |
| Disease | glucose measurement | TET2 PDE6C HLA-DRA TENT5C ACSL1 MYO3A MAP3K11 MAP3K15 PLEKHH2 WARS1 ANKH CTBP1 GPSM1 | 1.72e-04 | 380 | 303 | 13 | EFO_0004468 |
| Disease | Hematopoetic Myelodysplasia | 2.11e-04 | 29 | 303 | 4 | C2713368 | |
| Disease | Metastatic melanoma | 2.31e-04 | 54 | 303 | 5 | C0278883 | |
| Disease | colorectal cancer (implicated_via_orthology) | 2.42e-04 | 30 | 303 | 4 | DOID:9256 (implicated_via_orthology) | |
| Disease | Stomach Neoplasms | ERBB3 MTSS1 PTGS2 NDUFS1 NOP56 POLE PPP2R1A CHEK2 AKR1C3 MSLN RPL13 | 2.75e-04 | 297 | 303 | 11 | C0038356 |
| Disease | Malignant neoplasm of stomach | ERBB3 MTSS1 PTGS2 NDUFS1 NOP56 POLE PPP2R1A CHEK2 AKR1C3 MSLN RPL13 | 3.00e-04 | 300 | 303 | 11 | C0024623 |
| Disease | intestinal cancer (implicated_via_orthology) | 3.12e-04 | 32 | 303 | 4 | DOID:10155 (implicated_via_orthology) | |
| Disease | short QT syndrome (implicated_via_orthology) | 3.13e-04 | 3 | 303 | 2 | DOID:0050793 (implicated_via_orthology) | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 3.59e-04 | 14 | 303 | 3 | cv:C2931907 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 3.77e-04 | 169 | 303 | 8 | DOID:3908 (is_marker_for) | |
| Disease | Degenerative polyarthritis | 4.02e-04 | 93 | 303 | 6 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 4.02e-04 | 93 | 303 | 6 | C0086743 | |
| Disease | cancer (implicated_via_orthology) | 4.89e-04 | 268 | 303 | 10 | DOID:162 (implicated_via_orthology) | |
| Disease | neutrophil measurement | 5.13e-04 | 177 | 303 | 8 | EFO_0803548 | |
| Disease | Carcinoma of Male Breast | 6.22e-04 | 4 | 303 | 2 | C0238033 | |
| Disease | Breast Neoplasms, Male | 6.22e-04 | 4 | 303 | 2 | C0242788 | |
| Disease | MYELODYSPLASTIC SYNDROME | 6.34e-04 | 67 | 303 | 5 | C3463824 | |
| Disease | Muscle hypotonia | 6.55e-04 | 17 | 303 | 3 | C0026827 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 6.55e-04 | 17 | 303 | 3 | EFO_0021969 | |
| Disease | ductal carcinoma in situ (is_marker_for) | 6.75e-04 | 39 | 303 | 4 | DOID:0060074 (is_marker_for) | |
| Disease | susceptibility to mononucleosis measurement | 7.26e-04 | 69 | 303 | 5 | EFO_0008403 | |
| Disease | white matter microstructure measurement | UNC13D NCKAP5 PTHLH PLEKHG1 PLEC NME2 ARHGAP21 AMPD3 PPP4R3A RERGL TTLL4 SOS1 | 7.75e-04 | 390 | 303 | 12 | EFO_0005674 |
| Disease | Malignant neoplasm of breast | ERBB3 ABCA3 EZH2 PTGS2 PTHLH CNTN6 SYNJ2 MAP7D2 PURG RAD51B MICAL1 WARS1 KALRN DYNC2H1 NSD2 NUP98 SHMT1 TACC2 SORBS1 HDAC7 CHEK2 MACF1 HDLBP | 7.90e-04 | 1074 | 303 | 23 | C0006142 |
| Disease | Intellectual Disability | RALGAPA1 FRMPD4 SACS CCDC47 KIF5A NSD2 TTI2 FARSB SIN3A PPP2R1A TH MACF1 MAN1B1 | 7.97e-04 | 447 | 303 | 13 | C3714756 |
| Disease | kidney disease (implicated_via_orthology) | 8.18e-04 | 41 | 303 | 4 | DOID:557 (implicated_via_orthology) | |
| Disease | post-operative stroke, response to surgery | 1.03e-03 | 5 | 303 | 2 | EFO_0009951, EFO_0009956 | |
| Disease | teratoma (is_implicated_in) | 1.03e-03 | 5 | 303 | 2 | DOID:3307 (is_implicated_in) | |
| Disease | Hydronephrosis | 1.03e-03 | 5 | 303 | 2 | C0020295 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 1.03e-03 | 5 | 303 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | chronic myelomonocytic leukemia (is_implicated_in) | 1.03e-03 | 5 | 303 | 2 | DOID:0080188 (is_implicated_in) | |
| Disease | sexual dimorphism measurement | RALGAPA1 TET2 GDF5 ATXN2L SYN3 PTHLH UBN1 KCNH2 MAP3K11 PLEC GCN1 NPAS1 RAD51B RASGRF1 TENT5A UVSSA CHSY1 TH MYO1F ANKRD11 MACF1 CDK6 HDLBP | 1.16e-03 | 1106 | 303 | 23 | EFO_0021796 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.17e-03 | 45 | 303 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | Neuroblastoma | 1.37e-03 | 47 | 303 | 4 | C0027819 | |
| Disease | Bronchiectasis | 1.43e-03 | 22 | 303 | 3 | C0006267 | |
| Disease | WOLF-HIRSCHHORN SYNDROME | 1.53e-03 | 6 | 303 | 2 | 194190 | |
| Disease | VACTERL association (implicated_via_orthology) | 1.53e-03 | 6 | 303 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | Primary Myelofibrosis | 1.53e-03 | 6 | 303 | 2 | C0001815 | |
| Disease | 4p partial monosomy syndrome | 1.53e-03 | 6 | 303 | 2 | cv:C1956097 | |
| Disease | cortolone glucuronide (1) measurement | 1.53e-03 | 6 | 303 | 2 | EFO_0800552 | |
| Disease | Leukemia, Myelomonocytic, Chronic | 1.53e-03 | 6 | 303 | 2 | C0023480 | |
| Disease | spondyloepiphyseal dysplasia congenita (implicated_via_orthology) | 1.53e-03 | 6 | 303 | 2 | DOID:14789 (implicated_via_orthology) | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-b measurement | 2.09e-03 | 25 | 303 | 3 | EFO_0021970 | |
| Disease | lifestyle measurement, diastolic blood pressure | 2.13e-03 | 7 | 303 | 2 | EFO_0006336, EFO_0010724 | |
| Disease | nucleoside diphosphate kinase B measurement | 2.13e-03 | 7 | 303 | 2 | EFO_0020615 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 2.13e-03 | 7 | 303 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 2.13e-03 | 7 | 303 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 2.15e-03 | 173 | 303 | 7 | C0023467 | |
| Disease | Limb-girdle muscular dystrophy | 2.34e-03 | 26 | 303 | 3 | cv:C0686353 | |
| Disease | Depressive Symptoms | 2.34e-03 | 26 | 303 | 3 | C0086132 | |
| Disease | Ischemic stroke, fibrinogen measurement | 2.46e-03 | 55 | 303 | 4 | EFO_0004623, HP_0002140 | |
| Disease | essential hypertension, age at diagnosis | 2.63e-03 | 56 | 303 | 4 | EFO_0004918, MONDO_0001134 | |
| Disease | Pitt-Rogers-Danks Syndrome | 2.83e-03 | 8 | 303 | 2 | C0796117 | |
| Disease | phenol sulfate measurement | 2.83e-03 | 8 | 303 | 2 | EFO_0021011 | |
| Disease | body surface area | RALGAPA1 GDF5 HDAC11 ERBB3 SYN3 UBN1 KCNH2 PLEC RAD51B TENT5A CHSY1 ANKRD11 MACF1 HS6ST3 CDK6 | 2.88e-03 | 643 | 303 | 15 | EFO_0022196 |
| Disease | osteoarthritis (is_implicated_in) | 2.90e-03 | 28 | 303 | 3 | DOID:8398 (is_implicated_in) | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.90e-03 | 28 | 303 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | hemoglobin A1 measurement | TET2 SPTA1 TENT5C UNC13D PFKFB2 PTHLH ACSL1 PLEKHG1 MAP3K15 ANKH NUDT4 MACF1 GPSM1 | 3.02e-03 | 520 | 303 | 13 | EFO_0007629 |
| Disease | brain connectivity measurement | GDF5 ERBB3 NCKAP5 ENO4 PLEKHG1 PLEC RAD51B WARS1 GTSE1 PPP4R3A SOS1 | 3.04e-03 | 400 | 303 | 11 | EFO_0005210 |
| Disease | Neoplastic Cell Transformation | 3.21e-03 | 139 | 303 | 6 | C0007621 | |
| Disease | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | 3.38e-03 | 60 | 303 | 4 | EFO_0001365, EFO_0004683, EFO_1001492 | |
| Disease | Hereditary Diffuse Gastric Cancer | 3.47e-03 | 293 | 303 | 9 | C1708349 | |
| Disease | forced expiratory volume | TET2 GDF5 ATXN2L HLA-DRA HLX ITGA1 PTHLH RYR2 DST IFI44L MBD4 COG4 RAD51B MICAL1 AMPD3 PABPC4L LARS2 | 3.51e-03 | 789 | 303 | 17 | EFO_0004314 |
| Disease | creatinine measurement | TET2 SNX17 PFKFB2 AKR1C1 PTGS2 DDX1 CDKL5 MAP3K11 PLEC PLEKHH2 MBD4 DENND5B CHD9 SCLY SIN3A TH PPP3CA ANKRD11 CCDC158 RPL13 | 3.53e-03 | 995 | 303 | 20 | EFO_0004518 |
| Disease | lung cancer (implicated_via_orthology) | 3.61e-03 | 9 | 303 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | pyoderma gangrenosum | 3.61e-03 | 9 | 303 | 2 | EFO_0006835 | |
| Disease | Wolf-Hirschhorn Syndrome | 3.61e-03 | 9 | 303 | 2 | C1956097 | |
| Disease | HETE measurement | 3.81e-03 | 62 | 303 | 4 | EFO_0801166 | |
| Disease | spontaneous coronary artery dissection | 3.90e-03 | 31 | 303 | 3 | EFO_0010820 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 3.90e-03 | 31 | 303 | 3 | C1335167 | |
| Disease | Weight Gain | 4.09e-03 | 102 | 303 | 5 | C0043094 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.17e-03 | 195 | 303 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | Hypermetropia | 4.26e-03 | 103 | 303 | 5 | HP_0000540 | |
| Disease | Muscular Dystrophies, Limb-Girdle | 4.27e-03 | 32 | 303 | 3 | C0686353 | |
| Disease | heart conduction disease (implicated_via_orthology) | 4.27e-03 | 32 | 303 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | cholangiocarcinoma (is_marker_for) | 4.27e-03 | 64 | 303 | 4 | DOID:4947 (is_marker_for) | |
| Disease | carcinoma (implicated_via_orthology) | 4.27e-03 | 64 | 303 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | vesicular integral-membrane protein VIP36 measurement | 4.48e-03 | 10 | 303 | 2 | EFO_0022012 | |
| Disease | triple-negative breast cancer | 4.48e-03 | 10 | 303 | 2 | EFO_0005537 | |
| Disease | long QT syndrome (implicated_via_orthology) | 4.48e-03 | 10 | 303 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | adult onset asthma, body mass index | 4.48e-03 | 10 | 303 | 2 | EFO_0004340, EFO_1002011 | |
| Disease | red blood cell density measurement | RALGAPA1 TET2 SPTA1 TCIM TENT5C ITGA1 DST KIF2A PLEC RAD51B KALRN RICTOR SORBS1 PPP4R3A TVP23A FBXO21 HERC4 CDK6 | 4.63e-03 | 880 | 303 | 18 | EFO_0007978 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKARNFERVLGKITL | 16 | Q9NPJ3 | |
| VRRAAASKLGEFAKV | 181 | P30153 | |
| RSKIADGSVKREDIF | 66 | P17516 | |
| QGRAARAEEELRKKQ | 466 | Q9Y2J4 | |
| VSLASLKKQVDGERR | 221 | Q8WVB6 | |
| VRGKQFAQALRKFLE | 276 | O60825 | |
| ANKVLARIFKETELR | 696 | P21860 | |
| KDTSLLKEIRNRFGN | 906 | P53355 | |
| KLSLRFNGRVLFIKD | 191 | Q9H3F6 | |
| LNGSSKKLRAREALF | 2156 | Q9P281 | |
| DRVLFELTGRSKNKS | 216 | Q9Y6Q5 | |
| RKEFETNLRKTGLEL | 101 | Q75V66 | |
| LKELFRQQEAVRGKL | 2501 | Q6UB99 | |
| EGLKAFRGVDNKIRL | 96 | P54687 | |
| DEKALAQALKEGRIR | 271 | Q13363 | |
| RNFGLGKKSLEERIQ | 146 | P51589 | |
| LRRLFQSVKEKITGA | 16 | Q96NH3 | |
| KIFRNDRGRFKVVVS | 116 | Q5QJU3 | |
| KEINFLRRESEAGQK | 2046 | Q86TB3 | |
| RSKIADGSVKREDIF | 66 | P42330 | |
| EGARTKFAEELRAKA | 261 | Q9BWW8 | |
| DFASKRKEAELRSGI | 391 | P33121 | |
| RFLKKRISSDFEVGD | 371 | Q9H9E3 | |
| FRKGVIAVLAANRLK | 801 | Q6TFL3 | |
| GDRFAKQAIRRKVEL | 211 | Q96DB2 | |
| RGDFETFIKSKQERL | 406 | Q9NUQ8 | |
| DVKKDFRSVRLRDLG | 1181 | O00468 | |
| GALFFNKERTRNIVK | 216 | Q9HAR2 | |
| ETSQQALGKRFRKDA | 86 | Q8WTQ4 | |
| NRKKRFVFLGEAITL | 1971 | Q96DT5 | |
| SKVFRVGNKDRAAVR | 536 | Q99758 | |
| FNGKKALEAISRERG | 336 | Q96CM8 | |
| RDLKNGGRFVALKRV | 31 | Q00534 | |
| FTGFRKISLDDLRKA | 246 | Q9ULJ7 | |
| QFRRLFEKLAGKDSE | 536 | A6NHC0 | |
| ISKRKFAIGSAREAD | 251 | O96017 | |
| GFRLQKVLRESARDK | 46 | Q96C86 | |
| DFRKKARQSIQGILE | 441 | Q16581 | |
| DLRISAEGKAREFKV | 486 | A6NI56 | |
| FQRLDGSIKGELRKQ | 831 | O14646 | |
| QRASIIQRFRDGKEK | 376 | Q9UHL0 | |
| IRRKFEEKLRSFGQL | 161 | Q8NB25 | |
| DLRKEFQGQEAILRK | 286 | Q8NB25 | |
| FKGKEILRIRSESNQ | 906 | Q8NB25 | |
| EQKRFQLEELRKFGA | 536 | Q8WWM7 | |
| ITTKAGFLKRAARLD | 426 | Q7Z4T9 | |
| AEKRGRKITLRQVFD | 346 | Q01432 | |
| FKAIAQRELGRVKDE | 86 | Q9UFE4 | |
| AGFSEEELRRLKQTK | 6 | Q5T7V8 | |
| IKEGRRFNIDLVSKL | 221 | P24386 | |
| GNLKERNKFLAREAS | 226 | O15315 | |
| FRRDSIIGKVAIQKE | 86 | Q14644 | |
| KFRQKLEEALRESQG | 401 | Q8WWW0 | |
| TFKGLKLRFEQQRER | 636 | Q6IN85 | |
| SRRGKENLEFFELAK | 56 | Q99742 | |
| RLTERGVKFFQRKVE | 151 | P14920 | |
| LAERDGVKKRSQELA | 271 | Q8N6L0 | |
| VGEIIKRFEQKGFRL | 21 | P22392 | |
| KKQGLRIIFSDASRL | 491 | Q15124 | |
| EQKARKFSEFLSLRG | 496 | Q8IYY4 | |
| FVIDRQSGRLKLEKS | 2751 | Q14517 | |
| AGLEARKIVASFSKR | 106 | O94952 | |
| FVRTKSLKENIQRDG | 381 | Q9C0D6 | |
| FAERFKQRRIKLGVT | 271 | Q01851 | |
| GAKFIEVSKEARKRF | 66 | Q96AD5 | |
| AEKALFRALKTRGNT | 331 | O00567 | |
| RLEAVSRKQGAQFKE | 851 | P52948 | |
| EVKEGFKRLVARVFL | 296 | P58173 | |
| RAKLSKLVRETEQGA | 376 | Q96NT5 | |
| IAAKNEKSRSELGRF | 16 | Q9NU22 | |
| EKSRSELGRFLAKQV | 21 | Q9NU22 | |
| GRTKKRDLFFNEIKA | 346 | P43026 | |
| AVFSNLQRKGLEKRF | 281 | Q14774 | |
| EGFLKSDERQRLAKE | 46 | Q96T17 | |
| DAGEAAKILAEKRRQ | 396 | Q96T17 | |
| FGKIGRKDAERQLLS | 146 | P09769 | |
| DKDLFQREVLQRKGA | 111 | A0A1B0GTS1 | |
| QRKGAERIFKTDNLT | 121 | A0A1B0GTS1 | |
| SLLRRDASINFKAKG | 186 | Q8N201 | |
| AVEKQFGVKLDRRNA | 171 | Q9NVR5 | |
| EDEKLINATLRAGKR | 216 | Q96QG7 | |
| GDAFQKLRRVKELTL | 106 | Q86UE6 | |
| NRIRSITKKAFTGLD | 396 | Q6UXM1 | |
| LAIAKEFGDKAAERR | 236 | Q86YR5 | |
| FRRIDKDQDGKITRQ | 7206 | Q03001 | |
| ANGKRDVLFLRKTLT | 51 | A2RU37 | |
| FRVEGIKDNLDDIKR | 156 | Q53G44 | |
| NEDSKFLDVVLKRRG | 1781 | Q5SZK8 | |
| ELEGGFSRQRKRKLS | 876 | Q12809 | |
| DTIIRKFEGQSRKFL | 16 | Q9H252 | |
| QAGFEKLRRTRGEEK | 281 | Q9C098 | |
| FAVGTRKALVRLQKE | 261 | Q96A33 | |
| QNLERFKKGDVRFLI | 556 | Q92499 | |
| FTLKLKEAAVRQREA | 436 | Q6PIU1 | |
| RVLEAAVAAKKRFSV | 136 | Q14232 | |
| DAFTRNFLRKIGVKV | 171 | Q5JST6 | |
| NDFVVDATRKGNKIR | 671 | Q15910 | |
| NTIFDAKRLIGRKFE | 66 | P54652 | |
| AKRLIGRKFEDATVQ | 71 | P54652 | |
| VAAVLQIRSAEGRKK | 231 | P47888 | |
| KLGRLLGIFENQDRK | 76 | Q9NZJ9 | |
| KQAVRKALIEERGRF | 181 | O43312 | |
| DLKLAFKRIGDLQAA | 1921 | Q92614 | |
| RKLRVEVLGEIFKNS | 26 | P51160 | |
| RKSDFFINKRVRDVG | 26 | Q5GLZ8 | |
| GLVAKRDIRKGEFVN | 1076 | O96028 | |
| FKDGKELNRSRDIRI | 271 | O14511 | |
| VEEFLRRAKGKDQTS | 86 | Q49A26 | |
| VNKFLRGSNAESRKE | 21 | Q6UY01 | |
| ELNEIGRGRFSIVKK | 2686 | O60229 | |
| NTVFGAERKKRLSII | 141 | Q9Y2U5 | |
| FFRRIDKDQDGKITR | 3176 | O94854 | |
| KFQEARKLVERLGLE | 96 | Q9Y6K9 | |
| AAKFVNQLKGESRRV | 706 | Q16891 | |
| GETLARQRKLRLFKD | 221 | P35354 | |
| QNTVFDAKRLIGRKF | 66 | P34931 | |
| LGARVVLVEKRTKFS | 106 | Q8TDZ2 | |
| AIKAFRGQDDKIRVV | 206 | Q9H223 | |
| TLIDRFVKGRGQLDK | 421 | Q13421 | |
| IQDKKNFRRREGALF | 1426 | Q92616 | |
| KRSVFAALDTGRFKA | 396 | P57789 | |
| RDEKGRTALDLAAFK | 596 | Q8N8A2 | |
| AELKGFEVKRRGELQ | 966 | Q07864 | |
| KKISELFTLEGRRQV | 1181 | Q07864 | |
| LRNKEVKGALGRVFS | 296 | Q8NGQ2 | |
| VLKIRSAEGRRKAFN | 226 | Q8N628 | |
| IQKFSSRIREAKLAG | 176 | Q15070 | |
| AFTEARGARRGVKKV | 261 | P56199 | |
| RERQLEKGLVFLNGK | 51 | L0R8F8 | |
| RKSIGILNIFKDRSE | 716 | Q8NDA8 | |
| KGAVREIRKDNQFLA | 801 | P78316 | |
| DKDLFQREVLQRKGA | 111 | A0A1B0GWH4 | |
| LEDELQESRGFRKKI | 1086 | Q08378 | |
| ARELDGDRSKQLALK | 496 | Q86Y91 | |
| LRNKAVGEKVVRDAF | 181 | Q16795 | |
| GQLKEDREARFLASK | 271 | Q6R327 | |
| RSQGVERFIQESKLK | 111 | Q9NYZ3 | |
| LKDLTRFVDFNIKGR | 131 | Q8IZP7 | |
| VALDRLDRIGKKNSI | 706 | Q9Y3Q4 | |
| LLADIRKGFQLRKTA | 976 | Q27J81 | |
| KFRVQASKIRELLAE | 26 | Q8IVE3 | |
| DAKRLIGRKFADTTV | 71 | P48741 | |
| GEQAKAIFEKVKRFR | 231 | Q6P9F7 | |
| IENELIKFCREARGK | 56 | P55145 | |
| VFKNDARALEAARIK | 21 | Q5U5X0 | |
| RELSRLTGDKKFQEA | 406 | Q9UKM7 | |
| FKQRRIKLGFTQADV | 201 | P49335 | |
| ELRDKVKSFRAALQE | 676 | O00139 | |
| EKAALAIQGKFRRFQ | 46 | A6NKN8 | |
| ENKDRTILVERDGKF | 211 | Q5TID7 | |
| ARRLFRDKIVGAKEL | 2531 | Q8NCM8 | |
| RGKKGTDRAAQIELL | 341 | B5ME19 | |
| LRKVVGEFKDALRNS | 76 | Q9BSB4 | |
| KENLLGSIKEFRNRF | 1766 | P46100 | |
| ANRIISEAIAKAKER | 526 | Q3L8U1 | |
| SEAIAKAKERGERNI | 531 | Q3L8U1 | |
| FKGISRKDAERQLLA | 146 | P08631 | |
| LQVTDFGFAKRVKGR | 181 | P22612 | |
| KAAKDVLGFLRVVRF | 301 | P48547 | |
| VKALKRVQRNIGSFE | 1416 | Q9H799 | |
| RNFKLLDTRKLSRDG | 431 | Q9ULE3 | |
| KRILFQKITDRGDEL | 61 | Q5THR3 | |
| AKDGINRTALREIKL | 51 | P50613 | |
| AIKRKRTEALEQGGL | 326 | P50613 | |
| GRVFKATLVQAEKRS | 421 | Q14CM0 | |
| GERFRRDLVKTLKNL | 321 | P51686 | |
| QRAAVIERFREGKEK | 371 | Q9UMR2 | |
| DIGDITARKALRKQL | 431 | Q6P9A2 | |
| QREITLKGFREGSFK | 426 | Q9BQ39 | |
| KVAALSAKRAGELDR | 291 | Q5T0F9 | |
| RLQALAKRTGVAVEK | 456 | Q6ZUT9 | |
| NVGLVFVNSKRDRTK | 71 | Q9HCJ1 | |
| RQSKRIFLLEDGSLK | 451 | Q9UQ52 | |
| SDFNAIDKIRGKLRR | 201 | Q8NFW1 | |
| IFIIKGLRKSNAAER | 236 | P01903 | |
| DFKIGQKFNEKLRRS | 1421 | Q9NSI6 | |
| DKEDATRRFQILGKV | 51 | Q8WXX5 | |
| ELQAKIARLTKRFEA | 641 | Q6VMQ6 | |
| ERVVKQRLFGKTAGR | 91 | O95243 | |
| RKVAEAFARTGKSIE | 271 | P21695 | |
| SEVRKKLGEAAVRAA | 296 | Q96RQ3 | |
| FKDITRKDAERQLLA | 131 | P07948 | |
| QIKAGKAEIDRRISA | 151 | Q9NS73 | |
| LRIFFASKVQEDKGR | 161 | A6NNW6 | |
| KRNEKRIDLFGESQS | 411 | Q99518 | |
| RATAERVKALEGALK | 866 | Q12840 | |
| GQAEKRKTDQFLRDA | 171 | O75208 | |
| DRQQFKEEKTGTILR | 1131 | Q13683 | |
| DAKRLIGRKFADTTV | 71 | P17066 | |
| KLVNAGSERLRAVKD | 636 | Q5M9N0 | |
| KVASRELKNGFAVVR | 651 | Q8WUI4 | |
| AKRFKVRVGDRNTEQ | 281 | P00742 | |
| NIVELKEAFRRRGKL | 71 | O76039 | |
| DSILKRRDVGSAAFK | 1996 | Q9NZJ4 | |
| FNRFIRGLDALSKKA | 426 | Q92736 | |
| NKGITRARVEFNLKD | 1081 | Q6ZTR5 | |
| GATAAARKEVIRNKI | 386 | Q08209 | |
| REIQGLFDELRAKEK | 401 | Q16584 | |
| LFGIRAKRAKEAAEQ | 191 | P26373 | |
| DKGKDARLFVFRLSA | 546 | Q5VVW2 | |
| GEQAKALFEKVRKFR | 281 | Q7L1W4 | |
| NAFTLRTGVKEVARK | 281 | Q5TDP6 | |
| KDARFRIKGKVQDAR | 81 | Q9BY77 | |
| KVFVGRFKNRKDREA | 166 | P0CB38 | |
| FTLRNDKVKEALRDG | 286 | Q8NGT5 | |
| VKQSSRGRFLKIAEV | 76 | Q9UJV8 | |
| ARARQLVDAKKEDGF | 621 | Q96AX9 | |
| ILKIASAEGRRKAFA | 226 | P0C629 | |
| DVKGALRSAIIRKAA | 301 | Q8NGQ4 | |
| QVRESVIRFFLKGKD | 301 | Q8NH53 | |
| VRATLKEFKERLAGD | 441 | P34896 | |
| ELLREGFLRQVNKGK | 901 | Q6ZN16 | |
| RAGVLAERKALKDAA | 86 | Q9BYN8 | |
| ERKAFVVNIKEARGL | 166 | Q9H2B2 | |
| RFGSSKIDKELINRI | 106 | P23381 | |
| EAKAETIRNLRKSFA | 561 | O14994 | |
| QFLRLLERKEAGTKA | 346 | Q9H7C4 | |
| GLKFETSVRAKNDQR | 471 | Q12872 | |
| GELQRRKAALEGVSK | 161 | Q13049 | |
| RKAALEGVSKDLQAR | 166 | Q13049 | |
| QVFTRKGFLKEIRRS | 396 | Q13049 | |
| DTARARIGRKVFAKA | 666 | Q2YD98 | |
| FNSVKEKEERGIARL | 351 | Q9UQE7 | |
| RALRQAKNIVLKFEG | 76 | Q7Z5M5 | |
| AKNIVLKFEGRLTRT | 81 | Q7Z5M5 | |
| ELNEKKNERLRAAFG | 126 | Q9UQ35 | |
| KRAVESAVFLVGNKR | 111 | Q9H628 | |
| KDQRQRLGSKADFLE | 271 | Q9HBY8 | |
| FLVARRQAKKIENTG | 221 | Q96RI8 | |
| SRGGEEVLNRAFKKL | 306 | O15056 | |
| DAFLALTQKARGKRV | 421 | Q15031 | |
| LESKKAARAARFGIS | 116 | P82979 | |
| DFRDIKKRTRVVEGN | 26 | A0AVI2 | |
| QLEKRDFGKRLSLDS | 6 | O14513 | |
| VGEIIKRFEQKGFRL | 21 | P15531 | |
| SRFLEGKRAVEDKNI | 151 | P28331 | |
| DLAVVRSGRVKKAVA | 46 | Q1AE95 | |
| GVVARFVEFLKRKEN | 126 | P52294 | |
| FAERFKQRRIKLGVT | 261 | Q12837 | |
| IKRIESGAFRNLSKL | 161 | O94933 | |
| RLAEFKRAVKVATGQ | 346 | Q8IYU8 | |
| GTESLFFDKVRKALR | 461 | Q96ST3 | |
| KLKEGAENLRRATTD | 51 | Q16512 | |
| AIITGQVRLRKKAFA | 31 | O14684 | |
| INFSKRRKVAEITGE | 956 | Q07889 | |
| RERKLLEKAGFVQSG | 331 | Q96J65 | |
| VSSEGRFKNLREALK | 1166 | Q13972 | |
| AAKRARKEELTGVRF | 21 | O60287 | |
| AVAAVLRNIKFTKDR | 121 | Q9NSD9 | |
| NFRRESVLGEKSLKA | 741 | Q8WXE9 | |
| SGKNVELKFVDSVRR | 196 | Q96A09 | |
| NGKNVELKFVDSIRR | 161 | Q5VWP2 | |
| RSKIADGSVKREDIF | 66 | Q04828 | |
| RSKIADGSVKREDIF | 66 | P52895 | |
| EFAAKRKQAEVRSGI | 391 | Q9UKU0 | |
| LRRFEAGEKLSQIAK | 31 | B2RD01 | |
| INANAKTRGRIIDFK | 416 | Q86X52 | |
| INENAKSRGRLIDFK | 506 | Q70JA7 | |
| TNLKRFLGVEVERKL | 136 | Q8IZ96 | |
| KIVRAFFDNRNLRKG | 61 | Q96BS2 | |
| ALDFISGKRRAKQLS | 81 | Q6IBW4 | |
| LNLVDKVRRFGVAKV | 841 | Q9UPV9 | |
| EAKSRGSLVDFIKRF | 301 | Q92959 | |
| REKEDGAFSFVRKLQ | 166 | Q15036 | |
| ARKKEERQSLLGTEF | 1896 | O15417 | |
| SAGRKAKDIINAARE | 66 | Q96I15 | |
| EAKFGARRLARSLQK | 76 | P62380 | |
| ITVKDGLSLQFKRFR | 1651 | Q6GYQ0 | |
| LREEQRKFEKAGDTV | 416 | Q99973 | |
| IEIITDRQSGKKRGF | 141 | P22626 | |
| EARRGNVKDAVLKDL | 41 | Q6NXR4 | |
| RQDKDSEELLRKGFV | 686 | Q6ZVD7 | |
| ILALLERQVKKRGDF | 411 | Q6ZQQ2 | |
| TVRLSKKFEEINEGR | 831 | Q6ZQQ2 | |
| GLIERFTKDTARFKD | 46 | Q86SZ2 | |
| KEVGKDFLVRSRFLQ | 171 | Q9Y2P7 | |
| VVFRLGRIQADKAKG | 61 | Q8TAV4 | |
| RFGDLLNIDDTAKRK | 776 | Q9BX66 | |
| GIRNRDEVSFIKKLR | 116 | Q9BV90 | |
| IKINALVKEFREGRF | 1841 | Q9HCK1 | |
| LEGFRKNEEVLKRCA | 2846 | O95359 | |
| RFKGSRKDEILGIAN | 561 | Q86UX7 | |
| RVKQRLKRESDDFLG | 676 | O14795 | |
| EKRRQLIQESKFLGG | 141 | Q13123 | |
| QSFKERVAERGQKLE | 36 | P02549 | |
| KSKQRLEAEAGRFRE | 1921 | Q15149 | |
| RKASDSELERQKGLV | 2036 | Q15149 | |
| DGRRKIAFAITAIKG | 21 | P62269 | |
| DKGKSIQDLRRRFFL | 46 | P12272 | |
| KTRRVAAFRKNLVEL | 366 | Q9UNH7 | |
| IRSSAFDRKVQFLGK | 121 | P0DI81 | |
| LLQSFEDQGLRKRKF | 391 | Q9P2E3 | |
| RAERGRFLIKSNIVK | 241 | P86452 | |
| RSQGKGIFLFRRLKD | 171 | Q3SXZ7 | |
| GTAQVFSLVAERRKK | 1031 | Q6ZT12 | |
| LEKRVKELAQAARAA | 361 | Q9NPG3 | |
| RASLLKRGFKETAFL | 111 | O14904 | |
| FDRAEKFNRGIRKLG | 886 | Q2M389 | |
| EARKTKVQLALDRFR | 826 | Q9UI33 | |
| KEEERGAAIIQKAFR | 1731 | Q9UI33 | |
| KRAKRSTFLGLEADF | 761 | Q9ULL1 | |
| FGNEEELAFRKAKIR | 16 | A6NH52 | |
| NLDRAKAGLLERVKE | 1026 | Q00341 | |
| KDFRDRINGIKQLLS | 1501 | Q9Y4F4 | |
| ESLERLFRNSGDKKA | 46 | Q9NR00 | |
| IRSSAFDRKVQFLGK | 121 | P0DI82 | |
| LKRLTFQFGDARKDS | 76 | A0A087WT01 | |
| FTEAVRKLTARGFEK | 336 | Q14679 | |
| ERLFRGKLQEVTKSS | 1651 | Q5T5U3 | |
| ERFGQKGKAIRIERV | 1166 | Q6N021 | |
| GKNVELKFVDSLRRQ | 211 | Q96IP4 | |
| IGRGAKSVREFLEKN | 161 | O14818 | |
| RLNVRDKLDKVGVFL | 406 | Q9BVG3 | |
| DLTFDKRKTLGDLRQ | 556 | Q9NVE5 | |
| IAKGKLEFTRGQRIF | 2031 | Q6ZQQ6 | |
| LIKARARELSSGQKD | 676 | Q70J99 | |
| VEQITRKFRLNSEGK | 536 | Q8WY91 | |
| RKFRLNSEGKLEQTV | 541 | Q8WY91 | |
| FVRARVKKLLAAGVV | 631 | Q9H3U1 | |
| LVKKFGAQNVARRIE | 381 | Q9NYB0 | |
| AKGFRRAVSELDAKQ | 11 | P07101 | |
| AGARQKKGETRLDLV | 96 | Q6ZMR3 | |
| KEIIFRERNSKGQLE | 476 | Q9C099 | |
| LGKRERVDFADSVTK | 756 | O00160 | |
| KRKESAIIIQSAARG | 1081 | Q8NEV4 | |
| LQKVIRGFKDRSNFL | 751 | Q13402 | |
| FLDRTGLIEKKRLNR | 471 | Q9BWU0 |